0	1	{'start':(0, 0), 'end':(0, 10), 'text':'The integrin alphavbeta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1'}
7	34	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Introduction'}, {'start':(1, 0), 'end':(1, 23), 'text':'Cellular homeostasis is maintained in the organism through the correct responses to extra - , intra - , and intercellular signals ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 11), 'text':'Imbalances in these signals can result in disruption of cellular homeostasis ,'}, {'start':(2, 12), 'end':(2, 23), 'text':'leading to changes in cell mass and and or tissue organization .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 13), 'text':'The cellular homeostatic machinery consists of secreted , cell surface , and intracellular molecules'}, {'start':(3, 14), 'end':(3, 32), 'text':'that together maintain cellular differentiation and the balance between quiescence and entry into the cell cycle ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 8), 'text':'Homeostasis is regulated through the control of cell proliferation'}, {'start':(4, 9), 'end':(4, 22), 'text':'mediated through cell-extracellular matrix interactions in concert with growth promoting and inhibitory cytokines .'}]}, {'start':(5, 0), 'end':(5, 17), 'text':'A growth inhibitory cytokine of particular importance in tissue homeostasis is the multifunctional cytokine TGF-beta ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 11), 'text':'The important role of TGF-beta in homeostasis is illustrated by the fact'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 12), 'end':(6, 17), 'text':'that TGF-beta1-deficient mice develop epithelial hyperplasias'}, {'start':(6, 18), 'end':(6, 25), 'text':'( in addition to lethal multiorgan inflammation )'}]}, {'start':(6, 26), 'end':(6, 30), 'text':'within weeks after birth .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 37), 'text':'TGF-beta1 is normally maintained in a latent or inactive state by the noncovalent association of the bioactive peptide of TGF-beta1 with its NH 2 -terminal propeptide , latency associated peptide ( LAP ) - beta1 ( ) .'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 20), 'text':'Therefore , normal TGF-beta function is thought to be largely controlled by its activation from the latent state , a process'}, {'start':(8, 21), 'end':(8, 28), 'text':'that is not understood completely ( ) .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(9, 0), 'end':(9, 4), 'text':'However , recent evidence suggests'}, {'start':(9, 5), 'end':(9, 16), 'text':'that cell surface molecules or secreted extracellular molecules can activate TGF-beta .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 11), 'text':'Specifically , the integrin alphavbeta6 and the secreted extracellular matrix molecule thrombospondin'}, {'start':(10, 12), 'end':(10, 26), 'text':'( TSP ) -1 have been implicated in activation of TGF-beta1 through nonproteolytic mechanisms .'}]}, {'start':(11, 0), 'end':(11, 33), 'text':'In addition , plasmin or the cell surface localization of matrix metalloprotease MMP-9 by CD44 has been proposed to lead to activation of TGF-beta through proteolytic degradation of LAP-beta1 and LAP-beta2 , respectively .'}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(12, 0), 'end':(12, 22), 'text':'Although these mechanisms may be important to activation of TGF-beta , particularly in response to injury or during neoplastic progression ( ) ,'}, {'start':(12, 23), 'end':(12, 35), 'text':'they individually do not explain the activation of TGF-beta1 in normal tissues .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(13, 0), 'end':(13, 24), 'text':'Indeed , mice deficient in TSP-1 ( ) , plasminogen ( ) , CD44 ( ) , or alphavbeta6 ( ) are all born viable'}, {'start':(13, 25), 'end':(13, 43), 'text':'and are able to reproduce , in marked contrast to the uniform lethality of TGF-beta1-null mice ( ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 10), 'text':'The propeptide of TGF-beta1 , LAP-beta1 , contains an RGD motif'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 11), 'end':(14, 18), 'text':'that is recognized by a subset of integrins'}, {'start':(14, 19), 'end':(14, 28), 'text':'sharing in common the alphav integrin subunit ( ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(15, 0), 'end':(15, 23), 'text':'Thus , three of the five alphav integrins , alphavbeta1 , alphavbeta5 , and alphavbeta6 , have been shown to bind to LAP-beta1 ,'}, {'start':(15, 24), 'end':(15, 33), 'text':'and of these only alphavbeta6 can mediate TGF-beta activation .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(16, 0), 'end':(16, 3), 'text':'Recently , evidence suggests'}, {'start':(16, 4), 'end':(16, 20), 'text':'that alphavbeta6 mediated activation of TGF-beta1 plays an important role in response to injury ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(17, 0), 'end':(17, 6), 'text':'Of the two remaining alphav integrins ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(17, 7), 'end':(17, 12), 'text':'alphavbeta3 does not bind to LAP-beta1'}, {'start':(17, 13), 'end':(17, 20), 'text':'or mediate activation of TGF-beta1 ( ) ,'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(17, 21), 'end':(17, 26), 'text':'and alphavbeta8 has not been investigated'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(17, 27), 'end':(17, 28), 'text':'since ,'}, {'label':'condition', 'direction':'RightToLeft', 'children':[{'start':(17, 29), 'end':(17, 31), 'text':'until recently ,'}, {'start':(17, 32), 'end':(17, 44), 'text':'a system has not been available to study its function ( ) .'}]}]}]}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 7), 'text':'The alphavbeta8 integrin is of particular interest ,'}, {'start':(18, 8), 'end':(18, 22), 'text':'since it has been identified recently as an epithelial growth inhibitory molecule ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 8), 'text':'alphavbeta8 is expressed in the normal human airway epithelium'}, {'start':(19, 9), 'end':(19, 16), 'text':'but is lost in its malignant counterpart ,'}]}, {'start':(19, 17), 'end':(19, 25), 'text':'suggesting a role in epithelial homeostasis ( ) .'}]}, {'start':(20, 0), 'end':(20, 19), 'text':'Furthermore , heterologous expression of alphavbeta8 inhibits lung carcinoma cell growth both in vivo and in vitro ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(21, 0), 'end':(21, 15), 'text':'Since alphavbeta8 and TGF-beta1 are coexpressed in normal tissues , such as the human airway ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 16), 'end':(21, 19), 'text':'we considered the possibility'}, {'start':(21, 20), 'end':(21, 34), 'text':'that alphavbeta8 may participate in the maintenance of airway homeostasis through activation of TGF-beta .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 12), 'text':'In this article , we demonstrate a novel mechanism of cell growth regulation'}, {'start':(22, 13), 'end':(22, 22), 'text':'mediated by activation of TGF-beta1 via the integrin alphavbeta8 .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(23, 0), 'end':(23, 1), 'text':'We show'}, {'label':'joint', 'direction':'None', 'children':[{'start':(23, 2), 'end':(23, 6), 'text':'that alphavbeta8 can bind LAP-beta1'}, {'start':(23, 7), 'end':(23, 18), 'text':'and that the consequence of this interaction is activation of TGF-beta1 .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 10), 'text':'This mechanism of activation of TGF-beta1 differs from other reported mechanisms'}, {'start':(24, 11), 'end':(24, 30), 'text':'because it is regulated through the coordinated interactions of integrins , TGF-beta , and MMPs on the cell surface .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(25, 0), 'end':(25, 3), 'text':'Furthermore , we show'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(25, 4), 'end':(25, 4), 'text':'that'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 5), 'end':(25, 13), 'text':'when lung cancer cells are reconstituted with alphavbeta8 ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 14), 'end':(25, 21), 'text':'which is normally present on the epithelial cells'}, {'start':(25, 22), 'end':(25, 27), 'text':'from which they are derived ,'}]}]}, {'start':(25, 28), 'end':(25, 34), 'text':'growth is now inhibited by TGF-beta1 .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 7), 'text':'These data provide novel insights into the mechanisms'}, {'start':(26, 8), 'end':(26, 11), 'text':'underlying cellular homeostasis .'}]}]}]}]}]}]}]}
1	7	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(0, 0), 'end':(0, 7), 'text':'Integrins , matrix metalloproteases ( MMPs ) ,'}, {'start':(0, 8), 'end':(0, 27), 'text':'and the cytokine TGF-beta have each been implicated in homeostatic cell behaviors such as cell growth and matrix remodeling .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(1, 0), 'end':(1, 7), 'text':'TGF-beta exists mainly in a latent state ,'}, {'start':(1, 8), 'end':(1, 20), 'text':'and a major point of homeostatic control is the activation of TGF-beta .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 10), 'text':'Because the latent domain of TGF-beta1 possesses an integrin binding motif'}, {'start':(2, 11), 'end':(2, 14), 'text':'( RGD ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 15), 'end':(2, 22), 'text':'integrins have the potential to sequester latent TGF-beta'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 23), 'end':(2, 29), 'text':'( SLC ) to the cell surface'}, {'start':(2, 30), 'end':(2, 37), 'text':'where TGF-beta activation could be locally controlled .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 3), 'text':'Here , we show'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 4), 'end':(3, 11), 'text':'that SLC binds to alphavbeta8 , an integrin'}, {'start':(3, 12), 'end':(3, 21), 'text':'expressed by normal epithelial and neuronal cells in vivo .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 18), 'text':'This binding results in the membrane type 1 ( MT1 ) - MMP dependent release of active TGF-beta ,'}, {'start':(4, 19), 'end':(4, 32), 'text':'which leads to autocrine and paracrine effects on cell growth and matrix production .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 8), 'text':'These data elucidate a novel mechanism of cellular homeostasis'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 9), 'end':(5, 22), 'text':'achieved through the coordination of the activities of members of three major gene families'}, {'start':(5, 23), 'end':(5, 27), 'text':'involved in cell-matrix interactions .'}]}]}]}]}]}]}
230	325	{'label':'topic-change', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 2), 'text':'Materials and methods'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 3), 'text':'Cell lines and reagents'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 42), 'text':'Cell lines used include SW480 , HT1080 , H1264 , HepG2 , 293 , SP2 and 0 ( American Type Culture Collection ) , NCI H647 ( ) , the amphotrophic retroviral packaging line Phoenix ( ) , MvLu mink lung epithelial cells'}, {'start':(2, 43), 'end':(2, 51), 'text':'stably transfected with a plasminogen activator inhibitor promoter-1-luciferase construct'}]}, {'start':(2, 52), 'end':(2, 58), 'text':'( TMLC cells [ ] ) ,'}]}, {'start':(2, 59), 'end':(2, 64), 'text':'and High-Five ( Invitrogen ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 9), 'text':'Early passage parental H1264 cells deficient in MT1-MMP were subcloned'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(3, 10), 'end':(3, 12), 'text':'by limiting dilution'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 13), 'end':(3, 19), 'text':'to achieve a phenotypically stable MT1-MMP-negative subclone'}, {'start':(3, 20), 'end':(3, 23), 'text':'( H1264s ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 5), 'text':'LAP-beta1 was produced using recombinant baculovirus'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 6), 'end':(4, 15), 'text':'expressing wild-type simian LAP-beta1 and mutant ( RGE ) LAP-beta1'}, {'start':(4, 16), 'end':(4, 20), 'text':'as described ( ) .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 4), 'text':'LAP-beta1-Sepharose was prepared by cross'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 5), 'end':(5, 18), 'text':'linking 2 mg of protein A tagged LAP-beta1 to 1 ml of IgG Sepharose'}, {'start':(5, 19), 'end':(5, 23), 'text':'using 20 mM dimethylpimelimidate ;'}]}, {'start':(5, 24), 'end':(5, 31), 'text':'VN-Sepharose was prepared as described ( ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 26), 'text':'Human recombinant active TGF-beta1 , SLC , monoclonal anti-TGF-beta ( 1D11 ) and affinity purified anti-TGF-beta1 , -beta2 , and -beta3 were purchased from R&D Systems .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 9), 'text':'The following proteases and protease inhibitors were also purchased :'}, {'label':'joint', 'direction':'None', 'children':[{'start':(7, 10), 'end':(7, 47), 'text':'GM6001 ( ) and control C1006 ( AMS Scientific , Inc. ) , PMSF , E-64 ( Sigma-Aldrich ) , CK-23 ( Enzyme Systems Products ) , leupeptin , aprotinin , and pepstatin A ( Boehringer-Mannheim ) ,'}, {'start':(7, 48), 'end':(7, 60), 'text':'and human recombinant TIMP-1 , TIMP-2 , and Pro-MMP-2 ( Chemicon ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 7), 'text':'The following previously characterized antibodies were used :'}, {'start':(8, 8), 'end':(8, 49), 'text':'anti-beta8 , SN1 ( ) , anti-beta6 , 10D5 ( ) , E7P6 ( ) , polyclonal affinity purified rabbit anti-beta8 ( ) , anti-LAP-beta1 ( VB3A9 ) ( ) , and anti-CD-44 ( ) ( Developmental Studies Hybridoma Bank ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 8), 'text':'The following commercial antibodies and conjugates used were :'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 9), 'end':(9, 15), 'text':'anti-alpha5 ( P5D10 ; Chemicon ) ,'}, {'start':(9, 16), 'end':(9, 22), 'text':'anti-beta1 ( P5D2 ; Chemicon ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 23), 'end':(9, 34), 'text':'pan-anti-TGF-beta ( 1D11 ; R&D Systems ) , mouse or rabbit anti-MT1-MMP'}, {'start':(9, 35), 'end':(9, 40), 'text':'( Calbiochem and Chemicon ) ,'}]}]}, {'start':(9, 41), 'end':(9, 70), 'text':'mouse anti-BrdU ( Dako ) , phycoerythrin goat anti-mouse , rhodamine donkey anti-rabbit ( Chemicon ) , phycoerythrin goat anti-mouse , rhodamine goat anti-mouse ( Jackson ImmunoResearch Laboratories ) ,'}]}, {'start':(9, 71), 'end':(9, 95), 'text':'HRP conjugated sheep anti-mouse ( Amersham Pharmacia Biotech ) , HRP anti-rat ( Cappel ) , HRP protein A ( Amersham Pharmacia Biotech ) .'}]}]}, {'start':(10, 0), 'end':(10, 11), 'text':'VN was prepared from outdated fresh frozen human plasma ( ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 10), 'text':'Collagen type 1 was prepared from rat tails ( ) .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(12, 0), 'end':(12, 10), 'text':'Peptides ( GRGDSNK and GRGESNK ) were purchased ( BioMol )'}, {'start':(12, 11), 'end':(12, 23), 'text':'or were commercially synthesized ( GRRGDLATIH and GRRGELATIH ) ( BioSyn ) .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 5), 'text':'The following antibiotics were used :'}, {'label':'joint', 'direction':'None', 'children':[{'start':(13, 6), 'end':(13, 25), 'text':'puromycin , chloroquine ( Sigma-Aldrich ) , geneticin ( G418 ; GIBCO BRL ) , hygromycin ( Calbiochem ) ,'}, {'start':(13, 26), 'end':(13, 44), 'text':'and Fungizone , penicillin , and streptomycin ( University of California at San Francisco cell culture facility ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 6), 'text':'Retroviral vectors , constructs , and RT-PCR'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 30), 'text':'Retroviral vectors used were pLXSN ( CLONTECH Laboratories , Inc. ) , pBabe Puro ( a gift from Dr. Hartmund Land , Imperial Cancer Research Fund , London , UK )'}, {'start':(15, 31), 'end':(15, 42), 'text':'( ) , pBabebeta8Puro , pLXSNbeta8Neo ( ) , and pBabebeta6Puro .'}]}]}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 20), 'text':'The beta6 cDNA was subcloned from beta6-Peak10 ( a gift from R. Pytela , University of California at San Francisco )'}, {'start':(16, 21), 'end':(16, 24), 'text':'into pBabe Puro .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 9), 'text':'Plasmids were purified using the QIAGEN plasmid purification system .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 8), 'text':'beta8 truncation mutants were constructed using a PCR strategy'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 9), 'end':(18, 11), 'text':'introducing COOH-terminal truncations'}, {'start':(18, 12), 'end':(18, 25), 'text':'( amino acids 712 and 758 of the beta8 ORF [ ] ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 26), 'end':(18, 36), 'text':'which replace the cytoplasmic domain of full-length beta8 cDNA in pcDNAIneo'}, {'start':(18, 37), 'end':(18, 40), 'text':'( Invitrogen ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 13), 'text':'The mutant constructs were subcloned into pLXSN ( CLONTECH Laboratories , Inc. ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 6), 'text':'Truncated beta8 with a COOH-terminal AP tag'}, {'start':(20, 7), 'end':(20, 36), 'text':'( AP-alphavbeta8 ) was produced by in-frame blunt end ligation of the BspE1-Xho1 placental fragment from AP tag ( ) into a chimeric pcDNAIbeta8 and 3neo construct ( ) .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 7), 'text':'Full length MT1-MMP or transmembrane and cytoplasmic domain'}, {'start':(21, 8), 'end':(21, 9), 'text':'deleted MT1-MMP'}]}, {'start':(21, 10), 'end':(21, 36), 'text':'( DeltaMT1-MMP ) ( a gift from Stephen Weiss , University of Michigan , Ann Arbor , MI ) were subcloned into pBabe Puro or pLXSN .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 1), 'text':'A construct'}, {'start':(22, 2), 'end':(22, 6), 'text':'creating a MT1-MMP-GFP fusion protein'}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(22, 7), 'end':(22, 24), 'text':'( MT1-MMP-pLEGFP ) was created by destroying the stop codon of MT1-MMP in PCR3 .1 by PCR mutagenesis'}, {'start':(22, 25), 'end':(22, 31), 'text':'to create a unique HpaI site .'}]}]}, {'start':(23, 0), 'end':(23, 26), 'text':'The HindIII , HpaI MT1-MMP fragment was then subcloned in-frame into pLEGFP ( CLONTECH Laboratories , Inc. ) between a HindIII and Klenow treated BamHI site .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 13), 'text':'Sequencing in both orientations was performed to verify the fidelity of each construct .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 8), 'text':'Transfection of packaging cells and retroviral transduction was performed'}, {'start':(25, 9), 'end':(25, 13), 'text':'as described ( ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(26, 0), 'end':(26, 14), 'text':'Pools of beta8 expressing cells were either used within 72 h for short term experiments'}, {'label':'joint', 'direction':'None', 'children':[{'start':(26, 15), 'end':(26, 22), 'text':'or were sorted for uniform expression of beta8'}, {'start':(26, 23), 'end':(26, 37), 'text':'and propagated on type I collagen coated plates for long term experiments ( ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 7), 'text':'The ( SBE ) 4 -Lux reporter ,'}, {'start':(27, 8), 'end':(27, 24), 'text':'which contains 4 CAGACA repeats of the SMAD binding element of the JunB promoter ( ) ,'}]}, {'start':(27, 25), 'end':(27, 43), 'text':'was a gift of Peter ten Dijke ( Ludwig Institute for Cancer Research , Uppsala , Sweden ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 8), 'text':'Total cellular RNA was harvested using a commercial kit'}, {'start':(28, 9), 'end':(28, 12), 'text':'( QIAGEN ) ,'}]}, {'start':(28, 13), 'end':(28, 21), 'text':'and RT-PCR was performed as described ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 1), 'text':'Primers ,'}, {'start':(29, 2), 'end':(29, 30), 'text':'based on published sequences to MMP-2 , -7 , and -9 , MT1-MMP , ADAMS-9 , -10 and -17 , and beta-actin were purchased ( Operon Technologies ) .'}]}]}, {'start':(30, 0), 'end':(30, 7), 'text':'Annealing temperatures were based on published reports .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 8), 'text':'Affinity chromatography , ligand binding , and adhesion assays'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(32, 0), 'end':(32, 6), 'text':'125 I surface labeling and affinity chromatography'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(32, 7), 'end':(32, 8), 'text':'was performed'}, {'start':(32, 9), 'end':(32, 13), 'text':'as described ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(33, 0), 'end':(33, 0), 'text':'Plasmids'}, {'label':'joint', 'direction':'None', 'children':[{'start':(33, 1), 'end':(33, 8), 'text':'containing inserts for AP tagged truncated secreted beta8'}, {'label':'joint', 'direction':'None', 'children':[{'start':(33, 9), 'end':(33, 22), 'text':'and truncated secreted alphav in pCDM8 ( ) were stably expressed in 293 cells'}, {'start':(33, 23), 'end':(33, 29), 'text':'and characterized by immunoprecipitation ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 1), 'text':'Serum-free supernatant'}, {'start':(34, 2), 'end':(34, 3), 'text':'containing AP'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 4), 'end':(34, 4), 'text':'tagged'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 5), 'end':(34, 13), 'text':'alphavbeta8 ( alphavbeta8-AP ) was applied to 96-well plates'}, {'start':(34, 14), 'end':(34, 40), 'text':'precoated with LAP-beta1 ( wild-type and mutant ) , VN , or BSA for 1 h at 37degreesC in the presence and absence of monoclonal antibodies .'}]}]}]}, {'start':(35, 0), 'end':(35, 12), 'text':'Bound receptor was detected colorimetrically with pNPP ( Sigma-Aldrich ) at A405 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 0), 'end':(36, 5), 'text':'For affinity measurements , serum-free supernatant'}, {'label':'joint', 'direction':'None', 'children':[{'start':(36, 6), 'end':(36, 17), 'text':'containing secreted AP-alphavbeta8 was concentrated 40-fold ( Vivaspin 100 ; Vivascience )'}, {'label':'joint', 'direction':'None', 'children':[{'start':(36, 18), 'end':(36, 47), 'text':'and was applied to 10 mul of LAP-beta1-Sepharose , VN-Sepharose , or IgG-Sepharose ( Amersham Pharmacia Biotech ) in the presence or absence of 1 mg and ml RGD peptide'}, {'start':(36, 48), 'end':(36, 53), 'text':'and incubated overnight at 4degreesC .'}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 8), 'text':'The receptor concentration was determined against a standard curve'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 9), 'end':(37, 12), 'text':'generated using placental AP'}, {'start':(37, 13), 'end':(37, 17), 'text':'( Applied Biosystems ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 29), 'text':'The samples were washed three times in wash buffer ( Tris , 50 mM , pH 7.4 , NaCl , 150 mM , CaCl 2 , 1 mM ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 28), 'text':'Luminescence was determined using disodium 3 - ( 4-methoxyspiro ( 1,2-dioxetane-3 ,2 \' - [ ( 5 \' - chloro ) tricyclo ( 3,3.1.13.7 ) decan ] -4 -'}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(39, 29), 'end':(39, 44), 'text':'yl ) phenyl phosphate ( CSPD ) as a substrate ( Tropix ; Applied Biosystems )'}, {'start':(39, 45), 'end':(39, 51), 'text':'according to the manufacturer \'s instructions .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 5), 'text':'Specific binding was defined as binding'}, {'start':(40, 6), 'end':(40, 17), 'text':'that remained after incubation with a 200-fold excess of RGD peptide .'}]}, {'start':(41, 0), 'end':(41, 17), 'text':'Binding curves were generated using nonlinear regression ( Prism ; GraphPad Software ) from three independent experiments .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 3), 'text':'Adhesion assays were performed'}, {'start':(42, 4), 'end':(42, 8), 'text':'as described ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 6), 'text':'Production of monoclonal and polyclonal beta8 antibodies'}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(44, 0), 'end':(44, 12), 'text':'Balb and C mice were immunized by standard protocols with truncated secreted alphavbeta8'}, {'start':(44, 13), 'end':(44, 27), 'text':'according to the University of California at San Francisco Committee on Animal Research guidelines .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 0), 'end':(45, 9), 'text':'Splenocytes were fused with SP 2 and 0 myeloma cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 10), 'end':(45, 12), 'text':'using commercial protocols'}, {'start':(45, 13), 'end':(45, 16), 'text':'( Boehringer ) .'}]}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(46, 0), 'end':(46, 7), 'text':'Clones were screened by immunoprecipitation and flow cytometry'}, {'start':(46, 8), 'end':(46, 13), 'text':'to detect alphavbeta8 ( ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 0), 'end':(47, 6), 'text':'Antibodies were purified by ionic exchange chromatography'}, {'label':'joint', 'direction':'None', 'children':[{'start':(47, 7), 'end':(47, 8), 'text':'using FPLC'}, {'start':(47, 9), 'end':(47, 16), 'text':'or used as supernatants for flow cytometry .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(48, 0), 'end':(48, 4), 'text':'Polyclonal anti-beta8 antiserum was generated'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(48, 5), 'end':(48, 18), 'text':'and characterized as described ( ) by immunization of rabbits with a cytoplasmic peptide'}, {'start':(48, 19), 'end':(48, 21), 'text':'( TRAVTYRREKPEEIKMDISK )'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(48, 22), 'end':(48, 30), 'text':'corresponding to amino acids 740-759 of the beta8 ORF'}, {'start':(48, 31), 'end':(48, 34), 'text':'( BioSyn ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 8), 'text':'Fluorescence activated cell analysis , sorting , and immunocytochemistry'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 0), 'end':(50, 20), 'text':'For FACS ( R ) , beta8 expressing and mock transduced cells were detached using 7 mM EDTA in DME ,'}, {'start':(50, 21), 'end':(50, 30), 'text':'incubated with primary antibodies for 30 min at 4degreesC ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 31), 'end':(50, 34), 'text':'and detected with phycoerythrin'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 35), 'end':(50, 37), 'text':'conjugated secondary antibodies'}, {'start':(50, 38), 'end':(50, 41), 'text':'( Chemicon ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 6), 'text':'Stained cells were analyzed using a FACsort'}, {'start':(51, 7), 'end':(51, 19), 'text':'( R ) flow cytometer and CellQuest software ( Becton Dickinson ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(52, 0), 'end':(52, 4), 'text':'Immunofluorescence microscopy was performed essentially'}, {'start':(52, 5), 'end':(52, 13), 'text':'as described with the following modifications ( ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 1), 'text':'HT1080 cells'}, {'label':'joint', 'direction':'None', 'children':[{'start':(53, 2), 'end':(53, 18), 'text':'transduced with either pBabe Puro-beta8 or pBabe Puro underwent a second transduction with either MT1-MMP-pLEGFP or pLEGFP'}, {'start':(53, 19), 'end':(53, 24), 'text':'and were selected with G418 .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(54, 0), 'end':(54, 16), 'text':'LAP-beta1 was used to coat glass chamber slides at a concentration of 10 mug and ml ,'}, {'start':(54, 17), 'end':(54, 31), 'text':'and cells were allowed to attach to coated slides for 4 h before fixation .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 0), 'end':(55, 18), 'text':'Antibodies used were a polyclonal anti-beta8 antiserum and a monoclonal anti-GFP antibody ( CLONTECH Laboratories , Inc. ) .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(56, 0), 'end':(56, 10), 'text':'Secondary reagents were AlexaFluor 595 goat anti-rabbit ( Molecular Probes )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 11), 'end':(56, 19), 'text':'and biotinylated sheep anti-mouse ( Amersham Pharmacia Biotech )'}, {'start':(56, 20), 'end':(56, 29), 'text':'followed by Oregon green Streptavidin ( Molecular Probes ) .'}]}]}]}]}, {'start':(57, 0), 'end':(57, 20), 'text':'Confocal images were obtained using a Bio-Rad Laboratories MRC-1024 laser scanning confocal system and LaserSharp2000 software ( Bio-Rad Laboratories ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 0), 'end':(58, 8), 'text':'Pseudocolored images and composites were generated in Adobe Photoshop'}, {'start':(58, 9), 'end':(58, 16), 'text':'( R ) ( v. 6.0 ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 0), 'end':(59, 6), 'text':'Immunoprecipitation , Western blotting , and zymography'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(60, 0), 'end':(60, 12), 'text':'beta8 expressing or mock transduced cells in confluent 10-cm dishes were either surface'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(60, 13), 'end':(60, 34), 'text':'labeled with 125 I , biotin , or were directly lysed in PBS with 1 % Triton X-100 with 1 mM PMSF'}, {'start':(60, 35), 'end':(60, 37), 'text':'as described .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(61, 0), 'end':(61, 5), 'text':'Immunoprecipitations and Western blots were performed'}, {'start':(61, 6), 'end':(61, 8), 'text':'as described .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(62, 0), 'end':(62, 11), 'text':'For LAP-beta1 degradation experiments , LAP-beta1 ( 10 mug and ml )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(62, 12), 'end':(62, 20), 'text':'was added to individual wells of a 96-well plate'}, {'start':(62, 21), 'end':(62, 45), 'text':'containing beta8 overexpressing , MT1-MMP - , DeltaMT1-MMP - , or mock transduced H1264 cells ( 4 x 10 4 ) in complete medium .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(63, 0), 'end':(63, 12), 'text':'For GM6001 and C1006 inhibition experiments , 10 4 cells were added ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 13), 'end':(63, 16), 'text':'and for RGD peptide'}, {'start':(63, 17), 'end':(63, 26), 'text':'blocking experiments 2 x 10 4 cells were added .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(64, 0), 'end':(64, 8), 'text':'After a 12-16-h incubation , the medium was collected'}, {'label':'joint', 'direction':'None', 'children':[{'start':(64, 9), 'end':(64, 27), 'text':'and either added to TMLC reporter cells in the presence or absence of recombinant TGF-beta1 ( 10 pM )'}, {'start':(64, 28), 'end':(64, 40), 'text':'or was subjected to 12.5 % SDS-PAGE and Western blotting as above .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(65, 0), 'end':(65, 23), 'text':'For zymography , cells were incubated in serum-free media overnight in the presence or absence of pro-MMP-2 ( 10 ng and well ) .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(66, 0), 'end':(66, 2), 'text':'Supernatants were harvested'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(66, 3), 'end':(66, 4), 'text':'and loaded'}, {'label':'joint', 'direction':'None', 'children':[{'start':(66, 5), 'end':(66, 8), 'text':'without heating or reduction'}, {'start':(66, 9), 'end':(66, 22), 'text':'and resolved by 10 % SDS-PAGE ( 1 mg and ml gelatin ) .'}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(67, 0), 'end':(67, 33), 'text':'After three washes in 2.5 % Triton X-100 , the gels were incubated in substrate buffer ( 50 mM Tris-HCL , 5 mM CaCl 2 , 0.01 % NaN 3 , pH 8.0 )'}, {'start':(67, 34), 'end':(67, 39), 'text':'and incubated overnight at 37degreesC .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(68, 0), 'end':(68, 10), 'text':'Lucent bands of gelatinolytic activity were revealed by Coomassie staining .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(69, 0), 'end':(69, 3), 'text':'Digital images were acquired'}, {'start':(69, 4), 'end':(69, 12), 'text':'using Eastman Kodak Co. 1D 3.5.3 Imaging system .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(70, 0), 'end':(70, 5), 'text':'Composites were assembled in Adobe Photoshop'}, {'start':(70, 6), 'end':(70, 13), 'text':'( R ) ( v. 6.0 ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 0), 'end':(71, 1), 'text':'TGF-beta bioassay'}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(72, 0), 'end':(72, 8), 'text':'To determine TGF-beta activation in a coculture assay ,'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(72, 9), 'end':(72, 58), 'text':'TMLC cells were cultured with beta8 expressing or mock transduced cells in the presence or absence of anti-TGF-beta-blocking antibody ( 10 mug and ml , 1D11 ; R&D Systems ) , anti-beta8 ( 100 mug and ml , 37E1 ) or anti-beta6 ( 150 mug and ml , 10D5 )'}, {'start':(72, 59), 'end':(72, 61), 'text':'as described .'}]}]}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(73, 0), 'end':(73, 7), 'text':'To measure active TGF-beta in tumor tissue ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(73, 8), 'end':(73, 13), 'text':'equal weights of tumors were minced'}, {'start':(73, 14), 'end':(73, 24), 'text':'and incubated in sterile DME for 30 min at 4degreesC .'}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 0), 'end':(74, 1), 'text':'The supernatants'}, {'start':(74, 2), 'end':(74, 4), 'text':'containing active TGF-beta'}]}, {'start':(74, 5), 'end':(74, 15), 'text':'were harvested after centrifugation ( 20 g ) at 4degreesC .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(75, 0), 'end':(75, 12), 'text':'The pellets were then incubated in serum-free DME for 20 min at 80degreesC'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(75, 13), 'end':(75, 15), 'text':'to activate SLC'}, {'start':(75, 16), 'end':(75, 22), 'text':'after which the supernatants were harvested .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(76, 0), 'end':(76, 22), 'text':'The supernatants containing active or heat activated ( latent ) TGF-beta were then added to preplated TMLC cells with or without 1D11 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(77, 0), 'end':(77, 14), 'text':'For protease inhibitor assays , inhibitors were added at the initiation of the coculture .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(78, 0), 'end':(78, 11), 'text':'The maximal dose of each inhibitor was defined as the highest concentration'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(78, 12), 'end':(78, 21), 'text':'that did not inhibit the ability of the TMLC cells'}, {'start':(78, 22), 'end':(78, 28), 'text':'to respond to recombinant active TGF-beta .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(79, 0), 'end':(79, 26), 'text':'To measure soluble TGF-beta activity from cultured cells , 10 6 HT1080 or SW480 cells , either beta8 expressing , beta6 expressing , or mock transduced ,'}, {'start':(79, 27), 'end':(79, 49), 'text':'were incubated in 100 mul of complete medium with or without 37E1 or 10D5 for 1 h at 37degreesC with gentle rotation .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(80, 0), 'end':(80, 14), 'text':'Cell-free supernatants were harvested by centrifugation ( 20 g ) for 5 min at 4degreesC'}, {'start':(80, 15), 'end':(80, 29), 'text':'and then added to preplated TMLC cells in the presence or absence of 1D11 .'}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(81, 0), 'end':(81, 6), 'text':'For soluble receptor assays , conditioned medium'}, {'start':(81, 7), 'end':(81, 13), 'text':'obtained from overnight cultures of 293 cells'}]}, {'start':(81, 14), 'end':(81, 16), 'text':'expressing truncated alphavbeta8'}]}, {'start':(81, 17), 'end':(81, 19), 'text':'was used .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(82, 0), 'end':(82, 16), 'text':'Relative luciferase units were defined as activity minus the background activity of the TMLC reporter cells .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(83, 0), 'end':(83, 14), 'text':'In some experiments , the TMLC reporter cells themselves activated a small amount of TGF-beta'}, {'start':(83, 15), 'end':(83, 22), 'text':'as determined by inhibition with anti-TGF-beta-blocking antibodies .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(84, 0), 'end':(84, 2), 'text':'In these experiments'}, {'start':(84, 3), 'end':(84, 10), 'text':'when the test cells did not activate TGF-beta'}]}, {'start':(84, 11), 'end':(84, 26), 'text':'the relative luciferase units ( sample minus the TMLC background ) were less than zero .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(85, 0), 'end':(85, 6), 'text':'Cell proliferation assays and lung tumor xenographs'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(86, 0), 'end':(86, 12), 'text':'Cell cycle analysis was performed as described previously ( ) with the exception'}, {'start':(86, 13), 'end':(86, 25), 'text':'that some cells were treated overnight with 10 mug and ml LAP-beta1 .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(87, 0), 'end':(87, 4), 'text':'BrdU incorporation assays were performed'}, {'start':(87, 5), 'end':(87, 9), 'text':'as described ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(88, 0), 'end':(88, 7), 'text':'H647 tumor xenografts were established in nude mice'}, {'start':(88, 8), 'end':(88, 12), 'text':'as described ( ) ,'}]}, {'start':(88, 13), 'end':(88, 35), 'text':'and experiments were performed in full compliance with institutional guidelines and the University of California at San Francisco Committee on Animal Research .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(89, 0), 'end':(89, 1), 'text':'Statistical analysis'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(90, 0), 'end':(90, 11), 'text':'Student \'s t test was used for comparison of two datasets ;'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(90, 12), 'end':(90, 17), 'text':'analysis of variance ( ANOVA ;'}, {'start':(90, 18), 'end':(90, 38), 'text':'for parametric data ) or the Kruskal-Wallis test ( for nonparametric data ) were used for more than two datasets .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(91, 0), 'end':(91, 15), 'text':'Tukey \'s or Dunn \'s test was used for parametric or nonparametric data , respectively ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(91, 16), 'end':(91, 17), 'text':'to determine'}, {'start':(91, 18), 'end':(91, 22), 'text':'where the differences lay .'}]}]}, {'start':(92, 0), 'end':(92, 7), 'text':'Significance was defined as p < 0.05 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(93, 0), 'end':(93, 8), 'text':'Data are shown as means + /- 1 SEM'}, {'start':(93, 9), 'end':(93, 12), 'text':'unless otherwise noted .'}]}]}]}]}]}]}, {'start':(94, 0), 'end':(94, 13), 'text':'Statistical software used was InStat v2 .03 ( GraphPad Software , Inc. ) .'}]}]}]}]}
185	230	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Discussion'}, {'start':(1, 0), 'end':(1, 14), 'text':'We have found previously that the integrin alphavbeta8 inhibits epithelial cell growth ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(2, 0), 'end':(2, 16), 'text':'Furthermore , alphavbeta8 is expressed in either quiescent cells or cells with a low rate of turnover'}, {'start':(2, 17), 'end':(2, 28), 'text':'and is lost in the process of neoplastic transformation ( ) .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 5), 'text':'These findings led us to hypothesize'}, {'start':(3, 6), 'end':(3, 18), 'text':'that beta8 plays a role in the homeostatic control of normal tissues .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(4, 0), 'end':(4, 8), 'text':'In support of this hypothesis , we now demonstrate'}, {'start':(4, 9), 'end':(4, 37), 'text':'that the integrin alphavbeta8 mediates growth inhibition through a novel mechanism of activation of TGF-beta1 , a cytokine with a central role in homeostatic cellular processes ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 5), 'text':'Two molecular mechanisms have been proposed'}, {'start':(5, 6), 'end':(5, 14), 'text':'that may lead to the activation of TGF-beta1 :'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 15), 'end':(5, 16), 'text':'conformational change'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 17), 'end':(5, 27), 'text':'leading to activation of the SLC complex or proteolysis of LAP-beta1'}, {'start':(5, 28), 'end':(5, 35), 'text':'leading to the release of active TGF-beta1 .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 2), 'text':'Our data demonstrate'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(6, 3), 'end':(6, 14), 'text':'that a mechanism of conformational change leading to activation of TGF-beta ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(6, 15), 'end':(6, 27), 'text':'as proposed for the alphavbeta6 integrin ( ) or TSP-1 ( ) ,'}, {'start':(6, 28), 'end':(6, 37), 'text':'is not responsible for alphavbeta8 mediated activation of TGF-beta1 .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 25), 'text':'Specifically , alphavbeta8 mediated activation of SLC does not require the beta8 cytoplasmic domain in contrast to the mechanism of alphavbeta6 mediated activation of TGF-beta ,'}, {'start':(7, 26), 'end':(7, 34), 'text':'which requires the beta6 cytoplasmic domain ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 15), 'text':'Furthermore , alphavbeta8 is unlikely to bind directly or indirectly to LAP-beta1 through a TSP-1-dependent mechanism'}, {'label':'joint', 'direction':'None', 'children':[{'start':(8, 16), 'end':(8, 27), 'text':'because alphavbeta8 lacks the defined TSP-1 binding site for LAP-beta1 ( )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 28), 'end':(8, 34), 'text':'and alphavbeta8 does not bind to TSP-1'}, {'start':(8, 35), 'end':(8, 39), 'text':'( unpublished data ) .'}]}]}]}, {'start':(9, 0), 'end':(9, 13), 'text':'Moreover , unlike secreted TSP-1 ( ) secreted alphavbeta8 can not activate TGF-beta1 .'}]}]}]}]}]}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 3), 'text':'Thus , the mechanism'}, {'start':(10, 4), 'end':(10, 15), 'text':'by which alphavbeta8 activates TGF-beta1 is not dependent on conformational changes ,'}]}, {'start':(10, 16), 'end':(10, 42), 'text':'resulting from " inside-out " signal transduction as mediated by the beta6 cytoplasmic domain ( ) or direct physical interaction as mediated by TSP-1 ( ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 6), 'text':'Our findings support a biologically relevant mechanism'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 7), 'end':(11, 19), 'text':'whereby SLC binds with high affinity to alphavbeta8 on the cell surface ,'}, {'start':(11, 20), 'end':(11, 30), 'text':'which results in the metalloprotease dependent release of active TGF-beta .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 6), 'text':'Evidence to support this mechanism follows :'}, {'start':(12, 7), 'end':(12, 27), 'text':'secreted alphavbeta8 binds to LAP-beta1 with a high affinity with a dissociation constant similar to other TGF-beta receptors ( ) ;'}]}, {'start':(12, 28), 'end':(12, 43), 'text':'( b ) both synthetic and endogenous MMP inhibitors block alphavbeta8 mediated activation of TGF-beta1 ;'}]}, {'start':(12, 44), 'end':(12, 61), 'text':'( c ) reconstitution of MT1-MMP into the H1264 MT1-MMP-deficient cell line rescues alphavbeta8 mediated TGF-beta activation ;'}]}, {'start':(12, 62), 'end':(12, 71), 'text':'alphavbeta8 and MT1-MMP specifically colocalize in LAP-beta1 substrate contacts ;'}]}, {'start':(12, 72), 'end':(12, 106), 'text':'( e ) consistent with a proteolytic event , active TGF-beta is liberated by an alphavbeta8 dependent mechanism into the supernatants of tumor cell lines and into the aqueous phase of lung cancer xenografts ;'}]}, {'start':(12, 107), 'end':(12, 148), 'text':'( f ) the proteolytic substrate of alphavbeta8 - , MT1-MMP-dependent activation of TGF-beta1 is likely to be LAP-beta1 , since beta8 overexpressing , MT1-MMP-expressing H1264 cells cleave and inactivate LAP-beta1 , whereas beta8 overexpressing , MT1-MMP-deficient H1264 cells do not ;'}]}, {'start':(12, 149), 'end':(12, 176), 'text':'( g ) cleavage of LAP-beta1 requires the concomitant activity of both beta8 and MT1-MMP , since beta8 specific RGD inhibitors and metalloprotease inhibitors both block cleavage .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 31), 'text':'Precedent for such a proteolytic mechanism is that plasmin ( ) and MMP-9 ( ) have each been shown to activate TGF-beta1 and TGF-beta2 , respectively , by cleavage of LAP .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(14, 0), 'end':(14, 3), 'text':'It is also possible'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 4), 'end':(14, 14), 'text':'that MT1-MMP acts indirectly by proteolytically modifying the activity of alphavbeta8'}, {'start':(14, 15), 'end':(14, 28), 'text':'as suggested recently for the MT1-MMP-dependent modification of the integrin alphavbeta3 ( ) .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 9), 'text':'However , this is unlikely because of the following :'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 10), 'end':(15, 29), 'text':'cell lines expressing alphavbeta8 attach to LAP-beta1 equally well whether or not they express MT1-MMP ( unpublished data ) ,'}, {'start':(15, 30), 'end':(15, 42), 'text':'suggesting that coexpression of MT1-MMP does not modify the activity of alphavbeta8 ;'}]}, {'start':(15, 43), 'end':(15, 70), 'text':'( b ) flow cytometry of H1264 cells overexpressing both beta8 and MT1-MMP using two different anti-beta8 monoclonal antibodies shows no alteration in surface expression of alphavbeta8 ,'}]}, {'start':(15, 71), 'end':(15, 81), 'text':'indicating that antibody epitopes are preserved along with adhesive capability ;'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 82), 'end':(15, 90), 'text':'( c ) immunoprecipitations or Western blots of cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 91), 'end':(15, 95), 'text':'coexpressing alphavbeta8 and MT1-MMP ,'}, {'start':(15, 96), 'end':(15, 114), 'text':'using polyclonal antibodies against the cytoplasmic domain of beta8 , show no electrophoretic shift or proteolytic degradation products .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 12), 'text':'Therefore , we have no evidence of modification of alphavbeta8 by MT1-MMP .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 8), 'text':'How does MT1-MMP interact with the alphavbeta8-TGF-beta1 complex ?'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(18, 0), 'end':(18, 2), 'text':'Our data suggest'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(18, 3), 'end':(18, 3), 'text':'that'}, {'start':(18, 4), 'end':(18, 25), 'text':'upon ligation of alphavbeta8 with SLC , alphavbeta8 and MT1-MMP become closely associated to form a complex on the cell surface .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'temporal', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 10), 'text':'The cell surface appears to be required for productive interactions ,'}, {'start':(19, 11), 'end':(19, 25), 'text':'since the secreted forms of alphavbeta8 and MT1-MMP do not mediate activation of TGF-beta .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 21), 'text':'Evidence for a physical association on the cell surface is that alphavbeta8 and MT1-MMP colocalize in substrate contacts specifically on LAP-beta1 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 14), 'text':'The nature of the MT1-MMP-beta8 interaction awaits elucidation by coimmunoprecipitation and domain interaction studies .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(22, 0), 'end':(22, 16), 'text':'Because the localization of MT1-MMP in LAP-beta1 substrate contacts is dependent on the presence of beta8 ,'}, {'start':(22, 17), 'end':(22, 31), 'text':'it is likely that alphavbeta8-SLC interactions are required to initiate the recruitment of MT1-MMP .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 22), 'text':'The dynamic recruitment of MT1-MMP to alphavbeta8-TGF-beta complexes could provide a basis for the homeostatic regulation of TGF-beta activity in cellular microenvironments .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(24, 0), 'end':(24, 12), 'text':'Although reconstitution of wild-type MT1-MMP is sufficient to support alphavbeta8 mediated activation ,'}, {'start':(24, 13), 'end':(24, 19), 'text':'other metalloproteases could potentially be involved .'}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(25, 0), 'end':(25, 5), 'text':'For instance , MT1-MMP binds to'}, {'label':'joint', 'direction':'None', 'children':[{'start':(25, 6), 'end':(25, 14), 'text':'and is potently inhibited by TIMP-2 ( ) ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(25, 15), 'end':(25, 27), 'text':'but MT1-MMP-TIMP-2 complexes also serve as a cell surface receptor for MMP-2 ,'}, {'start':(25, 28), 'end':(25, 40), 'text':'and the function of this complex is activation of MMP-2 ( ) .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(26, 0), 'end':(26, 6), 'text':'As such , it is not inconceivable'}, {'start':(26, 7), 'end':(26, 19), 'text':'that MMP-2 could also be involved in alphavbeta8 mediated activation of TGF-beta .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 11), 'text':'However , in H1264s cells MMP-2 is unlikely to be involved ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(27, 12), 'end':(27, 27), 'text':'since TIMP-1 , a potent inhibitor of MMP-2 and weak inhibitor of MT1-MMP ( ) ,'}, {'start':(27, 28), 'end':(27, 37), 'text':'has no effect on alphavbeta8 mediated activation of TGF-beta .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 11), 'text':'In contrast , beta8 mediated TGF-beta activation is inhibited by TIMP-2 ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(28, 12), 'end':(28, 12), 'text':'suggesting'}, {'start':(28, 13), 'end':(28, 26), 'text':'that MT1-MMP may alone be sufficient to support beta8 mediated activation of TGF-beta .'}]}]}, {'start':(29, 0), 'end':(29, 34), 'text':'Although formally we can not exclude additional roles for other MMPs or related metalloproteases such as ADAMs or ADAMTS , family members in alphavbeta8 mediated activation of TGF-beta in other systems or cell types .'}]}]}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 43), 'text':'The beta8 subunit appears to be the only integrin subunit capable of coordinating metalloprotease activity with SLC bound to the cell surface because the other LAP-beta1 binding integrins are either incapable of activating TGF-beta ( ) or , in the case of alphavbeta6 ,'}, {'start':(30, 44), 'end':(30, 53), 'text':'activating TGF-beta via a metalloprotease independent pathway ( ) .'}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 14), 'text':'Furthermore , alphavbeta8 mediated TGF-beta activation is solely dependent on metalloproteases and not other proteases'}, {'start':(31, 15), 'end':(31, 29), 'text':'because inhibitors of aspartyl , serine , and cysteine proteases do not inhibit activation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 12), 'text':'Thus , alphavbeta8 mediated activation of TGF-beta1 is not dependent on other proteases'}, {'start':(32, 13), 'end':(32, 20), 'text':'that have been implicated in SLC activation ,'}]}, {'start':(32, 21), 'end':(32, 34), 'text':'including plasmin ( ) , calpain ( ) , and cathepsin ( ) .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(33, 0), 'end':(33, 9), 'text':'Integrins ( ) and other cell surface molecules ( )'}, {'start':(33, 10), 'end':(33, 22), 'text':'have also been shown to localize MMP activity to the cell surface .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 8), 'text':'For instance , the integrin alphavbeta3 has been shown'}, {'start':(34, 9), 'end':(34, 20), 'text':'to form an SDS stable cell surface complex with MMP-2 ( )'}]}, {'start':(34, 21), 'end':(34, 28), 'text':'and to colocalize with MT1-MMP ( ) ,'}]}, {'start':(34, 29), 'end':(34, 45), 'text':'whereas CD44 has been shown to mediate localization of MMP-9 ( ) to the cell surface .'}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 15), 'text':'However , alphavbeta3 and CD44 are unlikely to be required for alphavbeta8 mediated activation of TGF-beta'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 16), 'end':(35, 24), 'text':'because alphavbeta3 is not expressed in multiple cell lines'}, {'start':(35, 25), 'end':(35, 33), 'text':'that support alphavbeta8 mediated activation of TGF-beta ( )'}]}, {'start':(35, 34), 'end':(35, 50), 'text':'and because anti-CD44 antibodies do not inhibit alphavbeta8 mediated activation of TGF-beta ( unpublished data ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(36, 0), 'end':(36, 14), 'text':'The selective MMP dependence of alphavbeta8- but not alphavbeta6 mediated activation of TGF-beta1 clearly demonstrates'}, {'start':(36, 15), 'end':(36, 28), 'text':'that the mechanisms of alphavbeta8- and alphavbeta6 mediated activation of TGF-beta1 are different .'}]}, {'start':(37, 0), 'end':(37, 29), 'text':'A structural basis for these different mechanisms may be the striking difference in the predicted secondary structure of the extracellular domains of the beta8 and beta6 subunits ( ) .'}]}]}, {'start':(38, 0), 'end':(38, 15), 'text':'Different integrin mediated mechanisms of TGF-beta activation may have evolved to support distinct biologic functions .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 9), 'text':'For instance , in the airway epithelium , a site'}, {'start':(39, 10), 'end':(39, 19), 'text':'where beta8 is normally expressed ( ) , a mechanism'}]}, {'start':(39, 20), 'end':(39, 37), 'text':'to support a low and persistent level of activation of TGF-beta1 is necessary for homeostasis ( ) .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(40, 0), 'end':(40, 1), 'text':'We speculate'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 2), 'end':(40, 10), 'text':'that alphavbeta8 could sequester SLC to the cell surface'}, {'label':'joint', 'direction':'None', 'children':[{'start':(40, 11), 'end':(40, 19), 'text':'where , in response to an environmental cue ,'}, {'start':(40, 20), 'end':(40, 39), 'text':'changes in the local balance of MMP and TIMP activity could lead to alphavbeta8 dependent liberation of active TGF-beta1 .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 34), 'text':'Thus , alphavbeta8 mediated activation of TGF-beta1 might liberate the low levels of active TGF-beta1 sufficient to promote local paracrine effects but insufficient for undesirable local and systemic fibrogenic effects of TGF-beta1 ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(42, 0), 'end':(42, 1), 'text':'Conversely ,'}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(42, 2), 'end':(42, 21), 'text':'if alphavbeta6 were to liberate TGF-beta by an MMP dependent mechanism undesirable pathologic levels of TGF-beta might be released locally'}, {'start':(42, 22), 'end':(42, 26), 'text':'and into the systemic circulation'}]}, {'start':(42, 27), 'end':(42, 43), 'text':'because after injury expression of alphavbeta6 and MMPs ( ) are both strongly and rapidly induced .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 21), 'text':'In summary , abundant evidence implicates the cytokine TGF-beta1 , integrins , and MMPs as important mediators of homeostatic cell behaviors .'}, {'start':(44, 0), 'end':(44, 24), 'text':'This article provides the first evidence of the coordination of activity of members of these three major multigene families in the maintenance of homeostasis .'}]}]}]}]}]}]}
34	185	{'label':'topic-change', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Results'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 13), 'text':'The integrin alphavbeta8 binds with high affinity to the RGD site of recombinant LAP-beta1'}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 8), 'text':'To determine if alphavbeta8 can bind to the RGD'}, {'start':(2, 9), 'end':(2, 11), 'text':'containing LAP-beta1 ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 12), 'end':(2, 15), 'text':'we performed affinity chromatography'}, {'label':'joint', 'direction':'None', 'children':[{'start':(2, 16), 'end':(2, 19), 'text':'using surface radiolabeled alphavbeta8'}, {'start':(2, 20), 'end':(2, 23), 'text':'and immobilized LAP-beta1 .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 29), 'text':'Two bands of the appropriate kD for the alphav and beta8 subunits ( 150 and 90 kD , respectively ) bound to immobilized LAP-beta1 in a divalent cation dependent fashion'}, {'start':(3, 30), 'end':(3, 42), 'text':'as shown by elution with EDTA ( a , lanes 4-8 ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 10), 'text':'This binding was also dependent on the RGD sequence of LAP-beta1'}, {'start':(4, 11), 'end':(4, 26), 'text':'as demonstrated by the inability of RGE ( a , lanes 1 \' -3 \' )'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 27), 'end':(4, 31), 'text':'and the ability of RGD'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 32), 'end':(4, 34), 'text':'to elute alphavbeta8'}, {'start':(4, 35), 'end':(4, 44), 'text':'( a , lanes 4 \' -7 \' ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 15), 'text':'The identity of the alphav and beta8 subunits in the elution fractions was confirmed by immunoprecipitation'}, {'start':(5, 16), 'end':(5, 19), 'text':'( b ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 14), 'text':'Anti-beta8 antibodies immunoprecipitated 150- and 90-kD bands from the RGD and EDTA elution fractions ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 15), 'end':(6, 21), 'text':'which comigrated exactly with the two bands'}, {'start':(6, 22), 'end':(6, 41), 'text':'immunoprecipitated with anti-alphav and anti-beta8 antibodies from cell lysates ( b , RGD , EDTA , and LYSATE ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(7, 0), 'end':(7, 4), 'text':'Immunoprecipitations of the elution fractions'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 5), 'end':(7, 27), 'text':'using antibodies to the other RGD binding integrins present on HT1080 cells , namely alphavbeta5 and alpha5beta1 , failed to detect any proteins'}, {'start':(7, 28), 'end':(7, 32), 'text':'( unpublished data ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 7), 'text':'To measure the relative ability of truncated alphavbeta8'}, {'start':(8, 8), 'end':(8, 27), 'text':'to bind to LAP-beta1 and vitronectin ( VN ) , the only other known ligand for alphavbeta8 ( ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 28), 'end':(8, 36), 'text':'we developed solid phase binding assays for alphavbeta8-ligand interactions'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 37), 'end':(8, 39), 'text':'using alkaline phosphatase'}, {'start':(8, 40), 'end':(8, 49), 'text':'( AP ) - tagged alphavbeta8 ( AP-alphavbeta8 ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 3), 'text':'The ability of AP-alphavbeta8'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 4), 'end':(9, 16), 'text':'to bind to immobilized LAP-beta1 was confirmed by metabolic labeling and affinity chromatography'}, {'start':(9, 17), 'end':(9, 20), 'text':'( c ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 26), 'text':'Two bands of the appropriate molecular weight for the truncated alphav ( 140 kD ) and beta8-AP ( 130 kD ) subunits were eluted by RGD peptide'}, {'start':(10, 27), 'end':(10, 30), 'text':'( c ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 17), 'text':'No other metabolically labeled proteins from the cell supernatants were shown to bind to LAP-beta1 by this method'}, {'start':(11, 18), 'end':(11, 21), 'text':'( c ) .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 10), 'text':'In solid phase assays , considerably more AP-alphavbeta8 bound to wells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 11), 'end':(12, 22), 'text':'coated with LAP-beta1 ( 10 mug and ml ) than to wells'}, {'start':(12, 23), 'end':(12, 32), 'text':'coated with VN ( 100 mug and ml ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 9), 'text':'AP-alphavbeta8 did not bind to a mutant form of LAP'}, {'label':'joint', 'direction':'None', 'children':[{'start':(13, 10), 'end':(13, 26), 'text':'( LAP [ RGE ] ) with a single amino acid substitution in the integrin recognition sequence'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 27), 'end':(13, 45), 'text':'and was completely eluted by either RGD ( 1 mg and ml ) or EDTA ( 10 mM )'}, {'start':(13, 46), 'end':(13, 50), 'text':'( unpublished data ) .'}]}]}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(14, 0), 'end':(14, 17), 'text':'Furthermore , alphavbeta8 binding was almost completely inhibited by the monoclonal antibody 37E1 , specific to beta8 .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(15, 0), 'end':(15, 12), 'text':'The affinity of AP-alphavbeta8 for LAP-beta1-Sepharose was determined by saturation binding experiments .'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 3), 'text':'AP-alphavbeta8 bound to LAP-beta1'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 4), 'end':(16, 26), 'text':'with high affinity ( Kd 13 pM ) with binding saturation reached at ~ 50 % ligand occupancy ( e , Bmax :'}, {'start':(16, 27), 'end':(16, 35), 'text':'0.5 fM and 1 .0 fM LAP-beta1 ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 14), 'text':'Scatchard analysis revealed a single high affinity state of AP-alphavbeta8 , consistent with other reports'}, {'start':(17, 15), 'end':(17, 27), 'text':'that secreted alphav integrins are expressed in a constitutively active affinity state .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 36), 'text':'In contrast to the high affinity of AP-alphavbeta8 for LAP-beta1 , the affinity of AP-alphavbeta8 for VN , the only other known ligand for alphavbeta8 ( ) , was too low to be determined using this assay'}, {'start':(18, 37), 'end':(18, 41), 'text':'( unpublished data ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(19, 0), 'end':(19, 10), 'text':'Thus , alphavbeta8 binds preferentially to LAP-beta1 with high affinity ,'}, {'start':(19, 11), 'end':(19, 21), 'text':'and this binding is both RGD and divalent cation dependent .'}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 3), 'text':'To determine if alphavbeta8'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 4), 'end':(20, 12), 'text':'expressed on the cell surface could bind latent TGF-beta'}, {'start':(20, 13), 'end':(20, 19), 'text':'( SLC ) under physiologic conditions ,'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 20), 'end':(20, 24), 'text':'we performed cell adhesion assays'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 25), 'end':(20, 29), 'text':'using both SLC and LAP-beta1'}, {'start':(20, 30), 'end':(20, 33), 'text':'as immobilized ligands .'}]}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(21, 0), 'end':(21, 3), 'text':'beta8 expressing HT1080 cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 4), 'end':(21, 22), 'text':'bound significantly better to SLC than to LAP-beta1 at the 1.0 and 2.5 mug and ml coating concentrations ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 23), 'end':(21, 32), 'text':'whereas mock transduced HT1080 cells did not bind at all'}, {'start':(21, 33), 'end':(21, 36), 'text':'( f ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 12), 'text':'The reason for the increase in the alphavbeta8 dependent cell adhesion to SLC'}, {'start':(22, 13), 'end':(22, 18), 'text':'compared with LAP-beta1 is unclear .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 23), 'text':'However , it is likely that the presence of the mature TGF-beta1 peptide in SLC results in conformational differences between SLC and LAP-beta1 ,'}, {'start':(23, 24), 'end':(23, 36), 'text':'which could affect either receptor binding , stability , or coating efficiency .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(24, 0), 'end':(24, 3), 'text':'Thus , we show'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 4), 'end':(24, 20), 'text':'that SLC is the first and only known ligand capable of supporting stable alphavbeta8 mediated adhesion ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 21), 'end':(24, 35), 'text':'since VN , the only other known alphavbeta8 ligand , does not support stable alphavbeta8'}, {'start':(24, 36), 'end':(24, 40), 'text':'mediated adhesion ( ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 6), 'text':'The integrin alphavbeta8 mediates activation of SLC'}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(26, 0), 'end':(26, 8), 'text':'To determine the functional consequence of LAP-alphavbeta8 interactions ,'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(26, 9), 'end':(26, 14), 'text':'we assessed the ability of alphavbeta8'}, {'start':(26, 15), 'end':(26, 24), 'text':'to activate the endogenous SLC present in coculture systems .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 7), 'text':'These systems consisted of beta8 expressing or mock'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 8), 'end':(27, 9), 'text':'transduced cells'}, {'start':(27, 10), 'end':(27, 21), 'text':'cocultured with reporter cell lines ( TMLC [ ] or HepG2 -'}]}]}, {'start':(27, 22), 'end':(27, 39), 'text':'[ SBE ] 4 -Lux [ Jonk et al. , 1998 ] ) responsive to active TGF-beta .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(28, 0), 'end':(28, 1), 'text':'We found'}, {'label':'joint', 'direction':'None', 'children':[{'start':(28, 2), 'end':(28, 25), 'text':'that the TMLC reporter cell system was a more specific bioassay system for TGF-beta activity than the HepG2- ( SBE ) 4 -Lux system'}, {'start':(28, 26), 'end':(28, 35), 'text':'and was therefore used for most of these studies .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 8), 'text':'The TMLC system consists of mink lung epithelial cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 9), 'end':(29, 21), 'text':'stably transfected with a TGF-beta responsive fragment of the plasminogen activator inhibitor-1 promoter'}, {'start':(29, 22), 'end':(29, 28), 'text':'driving the luciferase gene ( ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(30, 0), 'end':(30, 6), 'text':'TMLC cells are highly responsive to TGF-beta'}, {'start':(30, 7), 'end':(30, 16), 'text':'and produce a very low background of TGF-beta activation .'}]}]}]}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 14), 'text':'TMLC cells can thus be used in coculture with other cell lines or cell-free fractions'}, {'start':(31, 15), 'end':(31, 28), 'text':'to test for the presence of active TGF-beta using luminescence as a readout .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 33), 'text':'In the HT1080 , SW480 , and H647 cell lines , heterologous expression of beta8 had either no effect or a slight effect on the cell surface expression of the other integrin beta subunits'}, {'start':(32, 34), 'end':(32, 43), 'text':'known to interact with the RGD motif ( ) .'}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 15), 'text':'The only significant differences were a reduction of surface expression of the beta5 subunit in beta8'}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(33, 16), 'end':(33, 16), 'text':'transduced'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 17), 'end':(33, 19), 'text':'compared with mock'}, {'start':(33, 20), 'end':(33, 25), 'text':'transduced HT1080 and SW480 cells .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(34, 0), 'end':(34, 2), 'text':'It is possible'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 3), 'end':(34, 13), 'text':'that these slight reductions in surface expression of alphavbeta5- on beta8'}, {'start':(34, 14), 'end':(34, 38), 'text':'expressing HT1080 and SW480 cells could potentially reduce the magnitude of the beta8 effect on adhesion to LAP-beta1 or influence the activation of TGF-beta .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 5), 'text':'However , this is unlikely ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(35, 6), 'end':(35, 12), 'text':'since the alphavbeta5 integrin binds very weakly'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 13), 'end':(35, 19), 'text':'and does not mediate adhesion to SLC'}, {'start':(35, 20), 'end':(35, 25), 'text':'( f , mock ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 0), 'end':(36, 15), 'text':'Heterologous expression of alphavbeta8 mediated activation of TGF-beta in HT1080 , SW480 , and MvLu cells'}, {'start':(36, 16), 'end':(36, 29), 'text':'as determined by coculture with either TMLC ( , a-d ) or HepG2 -'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 30), 'end':(36, 36), 'text':'( SBE ) 4 -Lux reporter cells'}, {'start':(36, 37), 'end':(36, 41), 'text':'( unpublished data ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'temporal', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 7), 'text':'TGF-beta activation was specifically mediated by alphavbeta8 ,'}, {'start':(37, 8), 'end':(37, 23), 'text':'since it was substantially inhibited by the anti-beta8 antibody , 37E1 ( , a-c ) .'}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 24), 'text':'The other RGD binding integrin heterodimers normally present in SW480 , HT1080 , and MvLu cells ( ) did not mediate significant activation of TGF-beta'}, {'start':(38, 25), 'end':(38, 37), 'text':'because mock transduced cells did not activate TGF-beta ( , a-c ) .'}]}]}]}]}]}]}]}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 4), 'text':'However , H647 cells ,'}, {'start':(39, 5), 'end':(39, 11), 'text':'which normally express alphavbeta6 ( ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 12), 'end':(39, 13), 'text':'activated TGF-beta'}, {'start':(39, 14), 'end':(39, 31), 'text':'( note the higher activation in mock H647 cells than in other cell lines in d ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 15), 'text':'This activation in mock transduced H647 cells could be completely inhibited by antibodies to beta6 ;'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 16), 'end':(40, 18), 'text':'activation in beta8'}, {'start':(40, 19), 'end':(40, 38), 'text':'expressing H647 cells could be completely inhibited by a combination of beta8 and beta6 antibodies ( unpublished data ) .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(41, 0), 'end':(41, 2), 'text':'These data demonstrate'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(41, 3), 'end':(41, 3), 'text':'that'}, {'start':(41, 4), 'end':(41, 16), 'text':'when beta8 and beta6 are coexpressed the resulting TGF-beta activation is additive .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'evaluation', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 2), 'text':'The TGF-beta isoform'}, {'start':(42, 3), 'end':(42, 15), 'text':'that was primarily responsible for TGF-beta activation in our system was TGF-beta1 ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(42, 16), 'end':(42, 37), 'text':'since TGF-beta1 isoform specific antibodies inhibited 80-90 % of the activation in SW480 , HT1080 , MvLu , and H647 cells ,'}, {'start':(42, 38), 'end':(42, 52), 'text':'whereas TGF-beta2 and TGF-beta3 isoform specific antibodies had minimal effect ( unpublished data ) .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(43, 0), 'end':(43, 0), 'text':'Evidence'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 1), 'end':(43, 14), 'text':'that the beta8 cytoplasmic domain is not required for alphavbeta8 mediated activation of TGF-beta'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(44, 0), 'end':(44, 18), 'text':'The mechanism of integrin alphavbeta6 mediated activation of TGF-beta is likely to depend on the transduction of mechanical forces'}, {'start':(44, 19), 'end':(44, 27), 'text':'to induce conformational changes of SLC ( ) .'}]}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'start':(45, 0), 'end':(45, 20), 'text':'Thus , alphavbeta6 mediated activation of TGF-beta is critically dependent on specific sequences within the beta6 cytoplasmic domain ( ) .'}, {'start':(46, 0), 'end':(46, 23), 'text':'However , the beta8 cytoplasmic domain has no similarity with the cytoplasmic domain of beta6 or any other integrin beta subunit ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(47, 0), 'end':(47, 3), 'text':'We have shown previously'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 4), 'end':(47, 15), 'text':'that the beta8 cytoplasmic domain is incapable of linking to the cytoskeleton'}, {'start':(47, 16), 'end':(47, 20), 'text':'to stabilize cell adhesion .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(48, 0), 'end':(48, 5), 'text':'Therefore , we sought to determine'}, {'start':(48, 6), 'end':(48, 16), 'text':'whether the beta8 cytoplasmic domain would influence interactions with LAP-beta1 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 17), 'text':'We expressed and tested a series of beta8 cytoplasmic deletion mutants ( , a-c ) for their ability'}, {'label':'joint', 'direction':'None', 'children':[{'start':(49, 18), 'end':(49, 22), 'text':'to mediate adhesion to LAP-beta1'}, {'start':(49, 23), 'end':(49, 29), 'text':'and to activate TGF-beta ( ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 0), 'end':(50, 30), 'text':'The complete ( TM ) cytoplasmic deletion mutant was expressed at sixfold lower surface levels than the partial ( 759 ) cytoplasmic deletion mutant or the wild-type ( FL ) subunit'}, {'start':(50, 31), 'end':(50, 34), 'text':'( c ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 15), 'text':'Low levels of surface expression of the TM mutant could be due to a decreased ability'}, {'start':(51, 16), 'end':(51, 31), 'text':'to associate with the alphav subunit , alterations in intracellular transport , or increased degradation .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'comparison', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 0), 'end':(52, 1), 'text':'SW480 cells'}, {'start':(52, 2), 'end':(52, 10), 'text':'expressing sixfold lower surface levels of the TM mutant'}]}, {'start':(52, 11), 'end':(52, 14), 'text':'compared with SW480 cells'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 15), 'end':(52, 29), 'text':'expressing the 759 mutant or the FL subunit adhered only slightly less well to LAP-beta1'}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(52, 30), 'end':(52, 36), 'text':'( TM adhesion saturation reached at 5'}, {'start':(52, 37), 'end':(52, 50), 'text':'compared with 2.5 mug and ml coating concentration for 759 and FL ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 9), 'text':'Unlike beta6 transduced SW480 cells ( ) , SW480 cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 10), 'end':(53, 23), 'text':'transduced with full-length or mutant forms of beta8 failed to spread appreciably on LAP-beta1'}, {'start':(53, 24), 'end':(53, 28), 'text':'( unpublished data ) .'}]}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(54, 0), 'end':(54, 3), 'text':'SW480 and HT1080 cells'}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(54, 4), 'end':(54, 19), 'text':'expressing the FL subunit and the TM and 759 mutants also mediated significant activation of TGF-beta'}, {'start':(54, 20), 'end':(54, 27), 'text':'compared with mock transduced cells ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(55, 0), 'end':(55, 10), 'text':'Concordant with sixfold lower levels of surface expression , SW480 cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 11), 'end':(55, 22), 'text':'expressing the TM mutant did not activate TGF-beta1 as well as cells'}, {'start':(55, 23), 'end':(55, 34), 'text':'expressing either 759 mutant or the FL subunit ( b ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 0), 'end':(56, 2), 'text':'However , cells'}, {'start':(56, 3), 'end':(56, 26), 'text':'expressing the TM mutant adhered to LAP-beta1 and activated TGF-beta only twofold less than the 759 or FL constructs ( , c-e ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 0), 'end':(57, 18), 'text':'This discordance may be due to dependence on the ligand concentration rather than the receptor number in these assays'}, {'start':(57, 19), 'end':(57, 24), 'text':'( e.g. , saturation ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(58, 0), 'end':(58, 4), 'text':'Alternatively , it is possible'}, {'start':(58, 5), 'end':(58, 20), 'text':'that the cytoplasmic domain of beta8 actually plays a negative regulatory role in alphavbeta8-TGF-beta interactions .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 0), 'end':(59, 7), 'text':'This latter possibility is consistent with the hypothesis'}, {'start':(59, 8), 'end':(59, 22), 'text':'that the divergent cytoplasmic domain of beta8 plays a general inhibitory role ( ) .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(60, 0), 'end':(60, 3), 'text':'Together these findings suggest'}, {'start':(60, 4), 'end':(60, 22), 'text':'that the cytoplasmic domain of beta8 is not required for either adhesion to LAP-beta1 or activation of TGF-beta .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 0), 'end':(61, 20), 'text':'Thus , it is likely that the mechanism of alphavbeta8 mediated activation of TGF-beta1 is distinct from the mechanosignal transduction mechanism'}, {'start':(61, 21), 'end':(61, 26), 'text':'described for alphavbeta6 ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(62, 0), 'end':(62, 13), 'text':'alphavbeta8 mediated activation of TGF-beta requires localization to the cell surface and metalloprotease activity'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 0), 'end':(63, 1), 'text':'The fact'}, {'start':(63, 2), 'end':(63, 15), 'text':'that the cytoplasmic domain of beta8 is not required for activation of TGF-beta1 suggests'}]}, {'start':(63, 16), 'end':(63, 36), 'text':'that alphavbeta8 mediated activation of TGF-beta might be regulated extracellularly either in the extracellular space or on the cell surface .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(64, 0), 'end':(64, 4), 'text':'To test these possibilities ,'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(64, 5), 'end':(64, 13), 'text':'we first tested the ability of soluble secreted alphavbeta8'}, {'start':(64, 14), 'end':(64, 17), 'text':'to activate TGF-beta .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(65, 0), 'end':(65, 4), 'text':'We found no evidence ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(65, 5), 'end':(65, 10), 'text':'using a variety of receptor preparations'}, {'start':(65, 11), 'end':(65, 23), 'text':'( supernatant containing secreted alphavbeta8 or lectin- or antibody purified receptor ) ,'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(65, 24), 'end':(65, 27), 'text':'that soluble secreted alphavbeta8'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(65, 28), 'end':(65, 30), 'text':'could activate TGF-beta'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(65, 31), 'end':(65, 33), 'text':'( with supernatant'}, {'start':(65, 34), 'end':(65, 40), 'text':'containing secreted alphavbeta8 or media control ;'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(65, 41), 'end':(65, 44), 'text':'relative luciferase units :'}, {'label':'joint', 'direction':'None', 'children':[{'start':(65, 45), 'end':(65, 51), 'text':'alphavbeta8 , 7.8 + /- 0.1 ;'}, {'start':(65, 52), 'end':(65, 64), 'text':'media control , 11.8 + /- 1.2 , p > 0.05 ) .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(66, 0), 'end':(66, 1), 'text':'This suggests'}, {'start':(66, 2), 'end':(66, 13), 'text':'that cell surface localization of alphavbeta8 is required for TGF-beta activation .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(67, 0), 'end':(67, 11), 'text':'Because proteolytic cleavage is a common mechanism of regulating cytokine activity ,'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(67, 12), 'end':(67, 18), 'text':'we tested the ability of protease inhibitors'}, {'start':(67, 19), 'end':(67, 26), 'text':'to block alphavbeta8 mediated activation of TGF-beta .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(68, 0), 'end':(68, 19), 'text':'GM6001 , a member of the hydroxamate class of protease inhibitors specific to metalloproteases , but not a control peptide'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(68, 20), 'end':(68, 25), 'text':'lacking the metal binding hydroxamate modification'}, {'start':(68, 26), 'end':(68, 29), 'text':'( C1006 ) ,'}]}]}, {'start':(68, 30), 'end':(68, 52), 'text':'significantly blocked alphavbeta8 mediated TGF-beta activation in SW480 and HT1080 cells ( 59.0 + /- 10.0 % inhibition using 5 muM GM6001 ;'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(68, 53), 'end':(68, 57), 'text':'0.0 + /- 0.9 %'}, {'start':(68, 58), 'end':(68, 67), 'text':'using 5 muM C1006 , p < 0.01 ) .'}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(69, 0), 'end':(69, 5), 'text':'This inhibition was specific to alphavbeta8'}, {'start':(69, 6), 'end':(69, 39), 'text':'because alphavbeta6 mediated activation of TGF-beta was not inhibited by GM6001 ( 5 muM ) in SW480 cells or HT1080 cells ( 1.0 + /- 0.1 % inhibition , p > 0.05 ) .'}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(70, 0), 'end':(70, 32), 'text':'Finally , other peptide and chemical inhibitors of aspartyl ( pepstatin A ) , serine ( PMSF , CK-23 , aprotinin , and leupeptin ) , or cysteine ( leupeptin and E64 )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(70, 33), 'end':(70, 42), 'text':'proteases had no effect on alphavbeta8 mediated activation of TGF-beta1'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(70, 43), 'end':(70, 49), 'text':'when used at the maximal nontoxic doses'}, {'start':(70, 50), 'end':(70, 53), 'text':'( b ) .'}]}]}]}]}]}]}]}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 0), 'end':(71, 12), 'text':'Together these data suggest a novel mechanism of alphavbeta8 mediated activation of TGF-beta1'}, {'start':(71, 13), 'end':(71, 21), 'text':'requiring both the cell surface and metalloprotease activity .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(72, 0), 'end':(72, 11), 'text':'Cell surface expression of alphavbeta8 is associated with liberation of active TGF-beta'}, {'start':(73, 0), 'end':(73, 28), 'text':'All previously described mechanisms of cell associated protease dependent activation of TGF-beta involve liberation of active TGF-beta from SLC , presumably as a result of degradation of LAP .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(74, 0), 'end':(74, 3), 'text':'Therefore , we hypothesized'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(74, 4), 'end':(74, 4), 'text':'that'}, {'start':(74, 5), 'end':(74, 40), 'text':'if a cell surface proteolytic event was involved in alphavbeta8- but not alphavbeta6 mediated activation of TGF-beta then active TGF-beta should be released by beta8- but not beta6 expressing cells into the cell culture supernatant .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(75, 0), 'end':(75, 4), 'text':'To test this hypothesis ,'}, {'start':(75, 5), 'end':(75, 24), 'text':'we assayed the supernatants of beta8 expressing , beta6 expressing , or mock transduced HT1080 cells for active TGF-beta .'}]}, {'start':(76, 0), 'end':(76, 13), 'text':'In HT1080 cells , beta8 was expressed at lower surface levels than beta6 .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(77, 0), 'end':(77, 18), 'text':'Concordant with lower expression levels , alphavbeta8 expressing cells activated less TGF-beta than alphavbeta6 expressing cells in coculture assays'}, {'start':(77, 19), 'end':(77, 22), 'text':'( b ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(78, 0), 'end':(78, 1), 'text':'However ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(78, 2), 'end':(78, 30), 'text':'when supernatants of beta8 expressing , beta6 expressing , and mock transduced HT1080 cells were tested only supernatant from beta8 expressing cells contained a significant amount of active TGF-beta'}, {'start':(78, 31), 'end':(78, 34), 'text':'( c ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(79, 0), 'end':(79, 19), 'text':'The presence of active TGF-beta in the cell supernatant of beta8 expressing cells was confirmed by inhibition with anti-TGF-beta antibodies'}, {'start':(79, 20), 'end':(79, 23), 'text':'( c ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(80, 0), 'end':(80, 20), 'text':'Specificity was demonstrated by inhibition with anti-beta8 antibodies and by the relative lack of active TGF-beta in the supernatant of mock'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(80, 21), 'end':(80, 23), 'text':'transduced HT1080 cells'}, {'start':(80, 24), 'end':(80, 27), 'text':'( c ) .'}]}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(81, 0), 'end':(81, 2), 'text':'Supernatant from beta6'}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(81, 3), 'end':(81, 20), 'text':'expressing HT1080 cells also had a slight but insignificant ( p > 0.05 ) increase in active TGF-beta'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(81, 21), 'end':(81, 23), 'text':'compared with mock'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(81, 24), 'end':(81, 25), 'text':'transduced cells'}, {'start':(81, 26), 'end':(81, 29), 'text':'( c ) .'}]}]}]}]}]}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(82, 0), 'end':(82, 19), 'text':'However , the presence of active TGF-beta in the cell supernatant of beta6 expressing cells was not beta6 specific ,'}, {'start':(82, 20), 'end':(82, 28), 'text':'since it was not blocked by anti-beta6 antibodies .'}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(83, 0), 'end':(83, 31), 'text':'The presence of active TGF-beta in the supernatant of this beta6 expressing cell pool is likely due to random differences in integrin independent release of active TGF-beta by different cell pools ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(83, 32), 'end':(83, 36), 'text':'but we can not exclude'}, {'start':(83, 37), 'end':(83, 51), 'text':'that it is due to an indirect effect of beta6 expression in HT1080 cells .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(84, 0), 'end':(84, 7), 'text':'Consistent with the above HT1080 cell data ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(84, 8), 'end':(84, 10), 'text':'we also found'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(84, 11), 'end':(84, 27), 'text':'that a small but significant amount of TGF-beta1 was present in the cell culture supernatant of beta8'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(84, 28), 'end':(84, 30), 'text':'expressing SW480 cells'}, {'start':(84, 31), 'end':(84, 48), 'text':'( relative luciferase units , 0.92 + /- 0.23 ; +37 E1 , 0.26 + /- 0.08 ;'}]}]}, {'start':(84, 49), 'end':(84, 53), 'text':'p < 0.05 ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(85, 0), 'end':(85, 19), 'text':'In summary , active TGF-beta is released into the supernatant of beta8 expressing cells through a beta8 dependent mechanism ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(85, 20), 'end':(85, 20), 'text':'suggesting'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(85, 21), 'end':(85, 29), 'text':'that alphavbeta8 binds SLC to the cell surface ,'}, {'start':(85, 30), 'end':(85, 43), 'text':'which facilitates the metalloprotease dependent release of active TGF-beta into the cell supernatant .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(86, 0), 'end':(86, 12), 'text':'Expression of membrane-type 1-MMP is sufficient to support alphavbeta8 mediated activation of TGF-beta'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(87, 0), 'end':(87, 21), 'text':'In the course of screening cell lines for this study , we identified one squamous lung carcinoma cell line , H1264 ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(87, 22), 'end':(87, 32), 'text':'that expressed a low level of alphavbeta8 on the cell surface'}, {'start':(87, 33), 'end':(87, 38), 'text':'but did not activate TGF-beta .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'temporal', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(88, 0), 'end':(88, 4), 'text':'The inability of H1264 cells'}, {'start':(88, 5), 'end':(88, 7), 'text':'to activate TGF-beta'}]}, {'start':(88, 8), 'end':(88, 17), 'text':'was not due to low expression levels of alphavbeta8 ,'}]}, {'start':(88, 18), 'end':(88, 33), 'text':'since overexpression of beta8 by retroviral transduction did not rescue activation ( relative luciferase units ;'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(88, 34), 'end':(88, 36), 'text':'beta8 transduced ,'}, {'start':(88, 37), 'end':(88, 49), 'text':'3.0 + /- 0.3 ; +37 E1 , 2.2 + /- 0.5 ;'}]}, {'start':(88, 50), 'end':(88, 57), 'text':'mock transduced , 3.0 + /- 0.4 ;'}]}, {'start':(88, 58), 'end':(88, 68), 'text':'+ / -37 E1 , 2.6 + /- 0.2 ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(89, 0), 'end':(89, 4), 'text':'Since our current findings suggested'}, {'start':(89, 5), 'end':(89, 22), 'text':'that cell surface expression of a metalloprotease cofactor was likely involved in alphavbeta8 mediated activation of TGF-beta ,'}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(89, 23), 'end':(89, 26), 'text':'we used H1264 cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(89, 27), 'end':(89, 34), 'text':'to facilitate the identification of the specific metalloprotease'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(89, 35), 'end':(89, 37), 'text':'( s )'}, {'start':(89, 38), 'end':(89, 45), 'text':'involved in alphavbeta8 mediated activation of TGF-beta .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(90, 0), 'end':(90, 10), 'text':'Thus , we generated a metalloprotease expression profile of H1264 cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(90, 11), 'end':(90, 21), 'text':'and compared it to profiles of the other tumor cell lines'}, {'start':(90, 22), 'end':(90, 26), 'text':'used in this study .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(91, 0), 'end':(91, 3), 'text':'We concentrated on metalloproteases'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(91, 4), 'end':(91, 10), 'text':'known to localize to the cell surface'}, {'start':(91, 11), 'end':(91, 61), 'text':'( MMP-2 [ ] , MMP-7 [ ] , MMP-9 [ Yu and Stamenkovic , 1999 ] , membrane-type 1 [ MT1 ] - MMP , and a disintegrin and a metalloprotease domain [ ADAM ] -9 , -10 , and -17 [ Primakoff and Myles , 2000 ] ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(92, 0), 'end':(92, 2), 'text':'Using reverse transcriptase'}, {'start':(92, 3), 'end':(92, 15), 'text':'( RT ) - PCR and gelatin zymography ( unpublished data ) ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(92, 16), 'end':(92, 17), 'text':'we found'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(92, 18), 'end':(92, 21), 'text':'that the only metalloprotease'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(92, 22), 'end':(92, 35), 'text':'that was deficient in H1264 cells , relative to the other tumor cell lines'}, {'start':(92, 36), 'end':(92, 40), 'text':'used in this study ,'}]}]}, {'start':(92, 41), 'end':(92, 43), 'text':'was MT1-MMP .'}]}]}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(93, 0), 'end':(93, 7), 'text':'To reconstitute MT1-MMP expression in H1264 cells ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(93, 8), 'end':(93, 18), 'text':'we introduced either a full-length ( MT1-MMP ) or a transmembrane'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(93, 19), 'end':(93, 23), 'text':'deleted secreted form of MT1-MMP'}, {'start':(93, 24), 'end':(93, 27), 'text':'( DeltaMT1-MMP ) .'}]}]}]}]}]}]}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(94, 0), 'end':(94, 15), 'text':'Expression or lack of expression of MT1-MMP in transduced or mock transduced H1264 cells was verified'}, {'start':(94, 16), 'end':(94, 21), 'text':'by immunoblotting ( b ) .'}]}]}]}]}]}, {'start':(95, 0), 'end':(95, 29), 'text':'Immunoblots revealed an appropriate 63-kD band in cell lysates from MT1-MMP-transduced H1264 cells ( b ) and a 54-kD band from the supernatant of DeltaMT1-MMP-transduced cells ( b ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(96, 0), 'end':(96, 23), 'text':'The absence of any bands in mock transduced cells confirmed the absence of MT1-MMP in the parental H1264 cell line ( b ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(97, 0), 'end':(97, 6), 'text':'Reconstituted MT1-MMP was active in H1264 cells'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(97, 7), 'end':(97, 21), 'text':'as determined by the ability of MT1-MMP-transduced but not DeltaMT1-MMP-transduced or mock transduced H1264 cells'}, {'start':(97, 22), 'end':(97, 37), 'text':'to cleave pro-MMP-2 to its fully active ( 59 kD ) form ( c ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(98, 0), 'end':(98, 4), 'text':'Secreted DeltaMT1-MMP possessed gelatinolytic activity'}, {'start':(98, 5), 'end':(98, 13), 'text':'as determined by zymography ( unpublished data ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(99, 0), 'end':(99, 1), 'text':'H1264 cells'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(99, 2), 'end':(99, 18), 'text':'transduced with either MT1-MMP , DeltaMT1-MMP , or vector alone ( mock ) underwent a second transduction'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(99, 19), 'end':(99, 24), 'text':'to overexpress similar levels of alphavbeta8'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(99, 25), 'end':(99, 29), 'text':'as determined by flow cytometry'}, {'start':(99, 30), 'end':(99, 43), 'text':'using the anti-beta8 antibody , 14E5 , or SN1 ( unpublished data ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(100, 0), 'end':(100, 5), 'text':'For beta8 overexpressing H1264 cells ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(100, 6), 'end':(100, 7), 'text':'only those'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(100, 8), 'end':(100, 26), 'text':'transduced with MT1-MMP and not DeltaMT1-MMP or vector alone ( mock ) were able to support activation of TGF-beta'}, {'start':(100, 27), 'end':(100, 30), 'text':'( b ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(101, 0), 'end':(101, 1), 'text':'H1264 cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(101, 2), 'end':(101, 15), 'text':'transduced with MT1-MMP alone supported a low level of alphavbeta8 mediated activation of TGF-beta'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(101, 16), 'end':(101, 46), 'text':'( relative luciferase units ; no monoclonal antibody , 2.7 + /- 0.2 ; +37 E1 , 1.3 + /- 0.0 ; +1 D11 , -0.3 + /- 0.01 ) ,'}, {'start':(101, 47), 'end':(101, 59), 'text':'which is consistent with their lower levels of surface expression of alphavbeta8 .'}]}]}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(102, 0), 'end':(102, 13), 'text':'A significant portion of the TGF-beta activation was specific to beta8 and to metalloproteases'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(102, 14), 'end':(102, 20), 'text':'because it was inhibited by anti-beta8 antibodies'}, {'start':(102, 21), 'end':(102, 29), 'text':'( 37E1 ) , TIMP-2 , and GM6001 .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(103, 0), 'end':(103, 12), 'text':'37E1 , TIMP-2 , and GM6001 were less efficient than the pan-TGF-beta antibody'}, {'start':(103, 13), 'end':(103, 15), 'text':'( 1D11 )'}]}, {'start':(103, 16), 'end':(103, 20), 'text':'in inhibiting TGF-beta activity .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(104, 0), 'end':(104, 10), 'text':'TIMP-2 , a relatively specific inhibitor of MT1-MMP ( ) ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(104, 11), 'end':(104, 17), 'text':'inhibited TGF-beta activation equally well as 37E1'}, {'start':(104, 18), 'end':(104, 21), 'text':'( c ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(105, 0), 'end':(105, 27), 'text':'The inability to completely block the beta8 - , MT1-MMP-dependent activation of TGF-beta with anti-beta8 antibodies and MMP inhibitors is likely due to a combination of factors :'}, {'start':(105, 28), 'end':(105, 52), 'text':'antibody efficacy , steric hindrance on the cell surface ( ) and and or the high heterologous expression levels of both beta8 and MT1-MMP .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(106, 0), 'end':(106, 6), 'text':'alphavbeta8 and MT1-MMP colocalize in substrate contacts'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(107, 0), 'end':(107, 6), 'text':'Our cell biologic and biochemical data indicated'}, {'start':(107, 7), 'end':(107, 19), 'text':'that alphavbeta8 and MT1-MMP were likely to associate on the cell surface .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(108, 0), 'end':(108, 3), 'text':'Thus , we hypothesized'}, {'start':(108, 4), 'end':(108, 18), 'text':'that upon ligation with LAP-beta1 , alphavbeta8 and MT1-MMP would cocluster in membrane complexes .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(109, 0), 'end':(109, 4), 'text':'To address this hypothesis ,'}, {'start':(109, 5), 'end':(109, 21), 'text':'we expressed an MT1-MMP fusion construct with a COOH-terminal green fluorescent protein ( GFP ) tag .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(110, 0), 'end':(110, 16), 'text':'The purpose of the GFP tag was to obviate the use of available commercial anti-MT1-MMP antibodies ,'}, {'start':(110, 17), 'end':(110, 27), 'text':'which we found unsuitable for immunocytochemistry ( unpublished data ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(111, 0), 'end':(111, 8), 'text':'MT1-MMP-GFP was expressed on the cell surface of beta8'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(111, 9), 'end':(111, 11), 'text':'expressing HT1080 cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(111, 12), 'end':(111, 16), 'text':'as determined by surface labeling'}, {'start':(111, 17), 'end':(111, 23), 'text':'followed by immunoprecipitation with anti-GFP antibodies .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(112, 0), 'end':(112, 11), 'text':'Anti-GFP antibodies immunoprecipitated two bands from MT1-MMP-GFP-expressing cells , the upper band'}, {'start':(112, 12), 'end':(112, 26), 'text':'representing the catalytically active form of MT1-MMP-GFP and the lower band the degraded form ,'}]}, {'start':(112, 27), 'end':(112, 32), 'text':'lacking the catalytic domain ( )'}]}, {'start':(112, 33), 'end':(112, 38), 'text':'( a , top ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(113, 0), 'end':(113, 8), 'text':'Furthermore , MT1-MMP-GFP was found to be functionally active'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(113, 9), 'end':(113, 21), 'text':'as determined by potentiation of the zymographic conversion of pro-MMP2 to active MMP2'}, {'start':(113, 22), 'end':(113, 27), 'text':'( a , bottom ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(114, 0), 'end':(114, 4), 'text':'We determined using confocal microscopy'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(114, 5), 'end':(114, 20), 'text':'that beta8 and MT1-MMP-GFP exactly colocalized in discrete clusters in the plane of an LAP-beta1 substrate'}, {'start':(114, 21), 'end':(114, 30), 'text':'using anti-beta8 and GFP antibodies ( , b-d ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'temporal', 'direction':'LeftToRight', 'children':[{'start':(115, 0), 'end':(115, 19), 'text':'The localization of beta8 to these substrate contacts was not due to " bleed-over " of the MT1-MMP-GFP signal ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(115, 20), 'end':(115, 27), 'text':'since the GFP signal was not intense enough'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(115, 28), 'end':(115, 29), 'text':'to visualize'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(115, 30), 'end':(115, 42), 'text':'without staining with an anti-GFP antibody and beta8 localization was seen in beta8'}, {'start':(115, 43), 'end':(115, 54), 'text':'expressing HT1080 cells not transduced with MT1-MMP-GFP ( , e-g ) .'}]}]}]}]}, {'label':'evaluation', 'direction':'RightToLeft', 'children':[{'start':(116, 0), 'end':(116, 2), 'text':'As expected ,'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(116, 3), 'end':(116, 17), 'text':'antibodies against the alphav subunit colocalized with antibodies against the beta8 subunit in these contacts'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(116, 18), 'end':(116, 23), 'text':'when cells were plated on LAP-beta1'}, {'start':(116, 24), 'end':(116, 28), 'text':'( unpublished data ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(117, 0), 'end':(117, 9), 'text':'Localization of beta8 was not dependent on MT1-MMP expression ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(117, 10), 'end':(117, 19), 'text':'since beta8 was found in substrate contacts in MT1-MMP-deficient beta8'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(117, 20), 'end':(117, 22), 'text':'expressing H1264 cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(117, 23), 'end':(117, 27), 'text':'plated on an LAP-beta1 substrate'}, {'start':(117, 28), 'end':(117, 32), 'text':'( unpublished data ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(118, 0), 'end':(118, 19), 'text':'Localization of MT1-MMP-GFP to substrate contacts was not due to nonspecific accumulation of GFP or to a staining artifact ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(118, 20), 'end':(118, 30), 'text':'since no substrate contacts were found with anti-GFP antibodies in GFP'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(118, 31), 'end':(118, 34), 'text':'transduced non-beta8-expressing HT1080 cells'}, {'start':(118, 35), 'end':(118, 42), 'text':'plated on LAP-beta1 ( , h-j ) .'}]}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(119, 0), 'end':(119, 12), 'text':'Localization of MT1-MMP to LAP-beta1 substrate contacts was dependent on beta8 expression ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(119, 13), 'end':(119, 23), 'text':'since no contacts were found in non-beta8-expressing , MT1-MMP-GFP-expressing HT1080 cells'}, {'start':(119, 24), 'end':(119, 28), 'text':'( unpublished data ) .'}]}]}]}]}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(120, 0), 'end':(120, 14), 'text':'Finally , the colocalization of beta8 and MT1-MMP to substrate contacts required ligand engagement ,'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(120, 15), 'end':(120, 20), 'text':'since no such contacts were found'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(120, 21), 'end':(120, 24), 'text':'when beta8 - ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(120, 25), 'end':(120, 25), 'text':'MT1-MMP-GFP'}, {'start':(120, 26), 'end':(120, 42), 'text':'expressing HT1080 cells were plated on an irrelevant ligand , collagen I ( , k-m ) .'}]}]}]}]}]}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(121, 0), 'end':(121, 20), 'text':'In conclusion , ligation of alphavbeta8 with LAP-beta1 results in the specific colocalization of alphavbeta8 and MT1-MMP in substrate contacts ,'}, {'start':(121, 21), 'end':(121, 29), 'text':'suggesting a biologically relevant and close physical interaction .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(122, 0), 'end':(122, 9), 'text':'Overexpression of MT1-MMP is sufficient to cleave and inactivate LAP-beta1'}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(123, 0), 'end':(123, 16), 'text':'To determine if proteolysis of LAP-beta1 could be a mechanism of alphavbeta8 mediated activation of TGF-beta ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(123, 17), 'end':(123, 22), 'text':'we incubated recombinant LAP-beta1 with beta8'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(123, 23), 'end':(123, 25), 'text':'overexpressing H1264 cells'}, {'start':(123, 26), 'end':(123, 36), 'text':'transduced with either MT1-MMP , DeltaMT1-MMP , or vector alone .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(124, 0), 'end':(124, 18), 'text':'After incubation of LAP-beta1 with mock or DeltaMT1-MMP-expressing H1264 cells , LAP-beta1 remained intact ( 32 kD ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(125, 0), 'end':(125, 4), 'text':'In contrast , we found'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(125, 5), 'end':(125, 10), 'text':'that almost all of the LAP-beta1'}, {'start':(125, 11), 'end':(125, 25), 'text':'incubated with MT1-MMP-expressing H1264 cells was smaller ( 26-28 kD ) than intact LAP-beta1 ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(125, 26), 'end':(125, 28), 'text':'suggesting proteolytic cleavage'}, {'start':(125, 29), 'end':(125, 35), 'text':'( a , lane 4 ) .'}]}]}]}, {'label':'temporal', 'direction':'LeftToRight', 'children':[{'start':(126, 0), 'end':(126, 10), 'text':'LAP-beta1 cleavage was dependent on the metalloprotease activity of MT1-MMP ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(126, 11), 'end':(126, 24), 'text':'since the metalloprotease inhibitor GM6001 but not a control peptide C1006 completely blocked cleavage'}, {'start':(126, 25), 'end':(126, 33), 'text':'( a , lanes 5 and 6 ) .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(127, 0), 'end':(127, 1), 'text':'To determine'}, {'start':(127, 2), 'end':(127, 10), 'text':'if LAP-beta1 cleavage was also dependent on alphavbeta8 ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(127, 11), 'end':(127, 14), 'text':'we developed a peptide'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(127, 15), 'end':(127, 21), 'text':'based on the human LAP-beta1 sequence ,'}, {'start':(127, 22), 'end':(127, 31), 'text':'which was a relatively specific inhibitor of alphavbeta8-LAP-beta1 interactions .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(128, 0), 'end':(128, 11), 'text':'In the H1264 system , the GRRGDLATIH peptide completely blocked alphavbeta8-LAP-beta1 interactions'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(128, 12), 'end':(128, 28), 'text':'while having a minimal effect on the binding of other RGD dependent integrins to VN or fibronectin'}, {'start':(128, 29), 'end':(128, 32), 'text':'( b ) .'}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(129, 0), 'end':(129, 4), 'text':'Using these peptide inhibitors ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(129, 5), 'end':(129, 6), 'text':'we determined'}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(129, 7), 'end':(129, 15), 'text':'that LAP-beta1 cleavage was also dependent on alphavbeta8 ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(129, 16), 'end':(129, 26), 'text':'since GRRGDLATIH but not the RGE mutant peptide inhibited LAP-beta1 cleavage'}, {'start':(129, 27), 'end':(129, 30), 'text':'( c ) .'}]}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(130, 0), 'end':(130, 17), 'text':'Thus , in the H1264 cell system , alphavbeta8 and MT1-MMP together are required for LAP-beta1 cleavage .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(131, 0), 'end':(131, 21), 'text':'Finally , alphavbeta8 - , MT1-MMP-dependent cleavage of LAP-beta1 is functionally relevant , since LAP-beta1 , after cleavage , loses the ability'}, {'start':(131, 22), 'end':(131, 32), 'text':'to inhibit the function of the recombinant mature TGF-beta1 peptide .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(132, 0), 'end':(132, 0), 'text':'TGF-beta'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(132, 1), 'end':(132, 17), 'text':'activated by the integrin alphavbeta8 in human lung cancer xenografts results in growth inhibition and tumor fibrosis'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(133, 0), 'end':(133, 11), 'text':'To test the physiologic relevance of alphavbeta8 mediated activation of TGF-beta1 ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(133, 12), 'end':(133, 20), 'text':'we employed the H647 lung carcinoma cell system ,'}, {'start':(133, 21), 'end':(133, 28), 'text':'which we have described recently ( ) .'}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(134, 0), 'end':(134, 3), 'text':'We employed this system'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(134, 4), 'end':(134, 16), 'text':'because beta8 is expressed mainly by the basal cells of the human airway'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(134, 17), 'end':(134, 22), 'text':'( ) , a cell type'}, {'start':(134, 23), 'end':(134, 42), 'text':'that is difficult to isolate in sufficient numbers for our studies and difficult to maintain in culture ( ) .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(135, 0), 'end':(135, 23), 'text':'Because we have demonstrated recently that the growth of beta8 expressing H647 cells was inhibited relative to mock transduced H647 cells ( ) ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(135, 24), 'end':(135, 25), 'text':'we asked'}, {'start':(135, 26), 'end':(135, 36), 'text':'if TGF-beta might be a mediator of that growth inhibition .'}]}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(136, 0), 'end':(136, 4), 'text':'To address this question ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(136, 5), 'end':(136, 20), 'text':'we determined BrdU incorporation as a measure of DNA synthesis in beta8 expressing and in mock'}, {'start':(136, 21), 'end':(136, 24), 'text':'transduced H647 cells .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(137, 0), 'end':(137, 1), 'text':'We determined'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(137, 2), 'end':(137, 6), 'text':'that the growth of beta8'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(137, 7), 'end':(137, 18), 'text':'expressing H647 cells was potently inhibited relative to mock transduced control cells'}, {'start':(137, 19), 'end':(137, 25), 'text':'as reflected by reduced BrdU incorporation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(138, 0), 'end':(138, 2), 'text':'In addition ,'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(138, 3), 'end':(138, 15), 'text':'since TGF-beta characteristically induces a cell cycle arrest late in G1 ( )'}, {'start':(138, 16), 'end':(138, 25), 'text':'we studied the cell cycle defect in H647 cells .'}]}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(139, 0), 'end':(139, 9), 'text':'Nonsynchronized beta8 expressing H647 cells displayed a partial G1 arrest'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(139, 10), 'end':(139, 21), 'text':'when compared with mock transduced H647 cells ( G1 fraction of beta8'}, {'start':(139, 22), 'end':(139, 32), 'text':'expressing H647 cells , 62 % + /- 3 % ;'}]}, {'start':(139, 33), 'end':(139, 48), 'text':'mock transduced H647 cells , 47 + /- 3 % , p < 0.05 ) .'}]}]}]}]}]}]}, {'label':'evaluation', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(140, 0), 'end':(140, 3), 'text':'Furthermore , we found'}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(140, 4), 'end':(140, 12), 'text':'that this beta8 dependent growth inhibition was also TGF-beta-dependent'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(140, 13), 'end':(140, 27), 'text':'because it could be reversed by TGF-beta antibodies or by recombinant LAP-beta1 ( for beta8'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(140, 28), 'end':(140, 30), 'text':'expressing H647 cells'}, {'start':(140, 31), 'end':(140, 51), 'text':'without LAP-beta1 , G1 fraction , 61 % ; with LAP-beta1 , 51 % , in a representative experiment ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(141, 0), 'end':(141, 13), 'text':'Thus , TGF-beta is a mediator of beta8 induced growth inhibition in vitro .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(142, 0), 'end':(142, 10), 'text':'To address if alphavbeta8 also mediated TGF-beta activation in vivo ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(142, 11), 'end':(142, 20), 'text':'we used beta8 expressing or mock transduced H647 cells ,'}, {'start':(142, 21), 'end':(142, 29), 'text':'which are tumorigenic in nude mice ( ) .'}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(143, 0), 'end':(143, 3), 'text':'Using this system ,'}, {'start':(143, 4), 'end':(143, 21), 'text':'we have found beta8 expressing tumors to be significantly smaller than their mock transduced counterparts ( ) .'}]}]}]}, {'label':'evaluation', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(144, 0), 'end':(144, 25), 'text':'Because fibrosis is one of the histologic hallmarks of increased TGF-beta activity ( ) , we examined beta8 expressing tumors histologically for evidence of fibrosis .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(145, 0), 'end':(145, 1), 'text':'We found'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(145, 2), 'end':(145, 3), 'text':'that beta8'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(145, 4), 'end':(145, 5), 'text':'expressing tumors'}, {'label':'contrast', 'direction':'None', 'children':[{'start':(145, 6), 'end':(145, 9), 'text':'were not only smaller'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(145, 10), 'end':(145, 15), 'text':'but were more fibrotic than tumors'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(145, 16), 'end':(145, 18), 'text':'derived from mock'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(145, 19), 'end':(145, 20), 'text':'transduced cells'}, {'start':(145, 21), 'end':(145, 24), 'text':'( b ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(146, 0), 'end':(146, 1), 'text':'To determine'}, {'start':(146, 2), 'end':(146, 20), 'text':'if the reduction in tumor size and the increase in stromal fibrosis were associated with increased active TGF-beta ,'}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(146, 21), 'end':(146, 26), 'text':'we used the TMLC reporter cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(146, 27), 'end':(146, 33), 'text':'to determine the active and SLC activities'}, {'start':(146, 34), 'end':(146, 44), 'text':'associated with beta8 expressing and mock transduced H647 tumor xenografts .'}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(147, 0), 'end':(147, 3), 'text':'Using this bioassay ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(147, 4), 'end':(147, 21), 'text':'there was a significant increase in the amount of active TGF-beta present in the aqueous fraction of beta8'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(147, 22), 'end':(147, 24), 'text':'expressing tumors relative'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(147, 25), 'end':(147, 27), 'text':'to control tumors'}, {'start':(147, 28), 'end':(147, 31), 'text':'( c ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(148, 0), 'end':(148, 12), 'text':'In contrast , the latent component of TGF-beta did not differ between tumors'}, {'start':(148, 13), 'end':(148, 18), 'text':'derived from beta8 expressing or mock'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(148, 19), 'end':(148, 21), 'text':'transduced H647 cells'}, {'start':(148, 22), 'end':(148, 25), 'text':'( c ) .'}]}]}]}]}]}]}]}]}]}]}, {'start':(149, 0), 'end':(149, 12), 'text':'Thus , in vivo alphavbeta8 can liberate physiologic levels of TGF-beta activity .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(150, 0), 'end':(150, 4), 'text':'Moreover , these data suggest'}, {'start':(150, 5), 'end':(150, 25), 'text':'that in normal tissues alphavbeta8 mediated activation of TGF-beta must be more tightly regulated than in the tumor xenograft model ,'}]}, {'start':(150, 26), 'end':(150, 36), 'text':'since fibrosis is only associated with pathologic states ( ) .'}]}]}]}
